Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
NM_007294.4(BRCA1):c.5585A>T (p.His1862Leu)	BRCA1	H1862L, H1815L, H1883L, H758L, H1708L, H1751L, H1774L, H1790L, H1792L, H1818L, H1819L, H1857L, H1859L, H450L, H582L, H591L, H632L, H645L, H646L, H669L, H688L, H689L, H691L, H711L, H1735L, H1791L, H1821L, H1835L, H1842L, H1843L, H1858L, H1861L, H1884L, H670L, H677L, H687L, H710L, H716L, H717L, H720L, H733L, H734L, H1565L, H1566L, H1693L, H1733L, H1734L, H1750L, H1773L, H1778L, H1793L, H1794L, H1795L, H1814L, H1820L, H1834L, H1836L, H649L, H671L, H712L, H714L, H719L, H755L, H756L, H781L, H993L, H1749L, H1772L, H1813L, H1860L, H1882L, H631L, H650L, H679L, H692L, H718L, H732L, H757L, H759L, H780L, H994L	Familial cancer of breast|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055637	17	41197702	17	43045685	55637	70304	rs80357183	NC_000017.11:43045684:T:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Benign/Likely benign	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5579A>C (p.His1860Pro)	BRCA1	H1860P, H1881P, H756P, H1813P, H1748P, H1771P, H1789P, H1812P, H1818P, H1857P, H1859P, H643P, H644P, H669P, H675P, H685P, H686P, H689P, H710P, H714P, H715P, H730P, H731P, H755P, H779P, H991P, H1706P, H1731P, H1732P, H1772P, H1790P, H1793P, H1811P, H1833P, H1840P, H1882P, H448P, H580P, H668P, H690P, H753P, H757P, H778P, H1563P, H1733P, H1749P, H1770P, H1788P, H1832P, H1841P, H1855P, H1858P, H1880P, H629P, H647P, H648P, H687P, H712P, H716P, H717P, H718P, H754P, H1564P, H1691P, H1747P, H1776P, H1791P, H1792P, H1816P, H1817P, H1819P, H1834P, H1856P, H589P, H630P, H667P, H677P, H708P, H709P, H732P, H992P	not provided	VCV000041833	17	41197708	17	43045691	41833	50272	rs201196020	NC_000017.11:43045690:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Benign	Jul 13, 2012	no assertion criteria provided							
NM_007294.4(BRCA1):c.5576C>G (p.Pro1859Arg)	BRCA1	P1859R, P1812R, P755R, P1880R, P1879R, P447R, P579R, P629R, P666R, P676R, P707R, P708R, P713R, P714R, P730R, P756R, P777R, P1732R, P1747R, P1787R, P1788R, P1810R, P1816R, P1839R, P1854R, P588R, P646R, P647R, P667R, P685R, P688R, P709R, P711R, P754R, P991R, P1690R, P1769R, P1770R, P1771R, P1775R, P1789R, P1790R, P1791R, P1818R, P1858R, P642R, P684R, P716R, P717R, P729R, P731R, P753R, P990R, P1562R, P1730R, P1731R, P1748R, P1792R, P1815R, P1817R, P1831R, P1840R, P1855R, P1856R, P1881R, P628R, P643R, P668R, P674R, P686R, P689R, P715R, P752R, P778R, P1563R, P1705R, P1746R, P1811R, P1832R, P1833R, P1857R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055634	17	41197711	17	43045694	55634	70301	rs80357322	NC_000017.11:43045693:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5572A>C (p.Ile1858Leu)	BRCA1	I1858L, I1879L, I1811L, I754L, I1561L, I1562L, I1730L, I1745L, I1786L, I1789L, I1830L, I1831L, I1856L, I1857L, I1880L, I578L, I666L, I675L, I685L, I688L, I713L, I716L, I729L, I753L, I777L, I989L, I1689L, I1731L, I1747L, I1774L, I1788L, I1809L, I1810L, I1814L, I1832L, I1838L, I1839L, I446L, I628L, I645L, I667L, I673L, I687L, I706L, I707L, I708L, I715L, I751L, I752L, I776L, I642L, I683L, I710L, I714L, I728L, I755L, I1704L, I1787L, I1815L, I1817L, I1853L, I1854L, I1878L, I1729L, I1746L, I1768L, I1769L, I1770L, I1790L, I1791L, I1816L, I1855L, I587L, I627L, I641L, I646L, I665L, I684L, I712L, I730L, I990L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000183951	17	41197715	17	43045698	183951	184864	rs765656957	NC_000017.11:43045697:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5558A>G (p.Tyr1853Cys)	BRCA1	Y1853C, Y1806C, Y749C, Y1874C, Y1556C, Y1557C, Y1699C, Y1740C, Y1741C, Y1742C, Y1784C, Y1765C, Y1783C, Y1811C, Y1825C, Y1827C, Y1849C, Y1852C, Y441C, Y636C, Y640C, Y668C, Y670C, Y679C, Y683C, Y709C, Y710C, Y724C, Y746C, Y771C, Y772C, Y1785C, Y1805C, Y1809C, Y1810C, Y1826C, Y1850C, Y573C, Y622C, Y661C, Y680C, Y682C, Y701C, Y703C, Y711C, Y725C, Y748C, Y750C, Y985C, Y1724C, Y1781C, Y1782C, Y1786C, Y1812C, Y1833C, Y1873C, Y1875C, Y582C, Y623C, Y641C, Y660C, Y702C, Y705C, Y747C, Y1684C, Y1725C, Y1726C, Y1763C, Y1764C, Y1769C, Y1804C, Y1834C, Y1848C, Y1851C, Y637C, Y662C, Y678C, Y707C, Y708C, Y723C, Y984C	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055627	17	41197729	17	43045712	55627	70294	rs80357258	NC_000017.11:43045711:T:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5531T>G (p.Leu1844Arg)	BRCA1	L1844R, L740R, L1865R, L1797R, L1732R, L1775R, L1776R, L1796R, L1801R, L1825R, L1841R, L1864R, L573R, L627R, L628R, L631R, L653R, L659R, L739R, L1675R, L1690R, L1754R, L1756R, L1760R, L1800R, L1803R, L1817R, L1842R, L1866R, L564R, L613R, L632R, L651R, L692R, L698R, L699R, L702R, L716R, L975R, L976R, L1548R, L1717R, L1731R, L1755R, L1772R, L1773R, L1802R, L1818R, L1824R, L1840R, L614R, L652R, L671R, L674R, L696R, L701R, L738R, L741R, L1547R, L1715R, L1716R, L1733R, L1774R, L1777R, L1795R, L1816R, L1839R, L1843R, L432R, L661R, L669R, L670R, L673R, L693R, L694R, L700R, L714R, L715R, L737R, L762R, L763R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055615	17	41197756	17	43045739	55615	70282	rs80357323	NC_000017.11:43045738:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5523T>G (p.Ser1841Arg)	BRCA1	S1862R, S737R, S1794R, S1841R, S1672R, S1728R, S1753R, S1757R, S1769R, S1772R, S1792R, S1797R, S1813R, S1815R, S1821R, S1822R, S1863R, S429R, S625R, S629R, S697R, S699R, S711R, S734R, S760R, S1544R, S1545R, S1687R, S1729R, S1752R, S1770R, S1773R, S1774R, S1799R, S1837R, S650R, S666R, S667R, S668R, S689R, S690R, S691R, S1712R, S1714R, S1771R, S1798R, S1800R, S1836R, S1840R, S570R, S610R, S628R, S648R, S649R, S656R, S670R, S695R, S696R, S698R, S712R, S713R, S736R, S759R, S973R, S1713R, S1730R, S1751R, S1793R, S1814R, S1838R, S1839R, S1861R, S561R, S611R, S624R, S658R, S671R, S693R, S735R, S738R, S972R	Hereditary breast ovarian cancer syndrome	VCV000869006	17	41197764	17	43045747	869006	853157	rs878854960	NC_000017.11:43045746:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Jan 11, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5516T>C (p.Leu1839Ser)	BRCA1	L1839S, L1792S, L735S, L1860S, L1728S, L1751S, L1770S, L1837S, L427S, L609S, L626S, L627S, L656S, L669S, L688S, L695S, L733S, L757S, L758S, L970S, L1542S, L1749S, L1767S, L1771S, L1772S, L1795S, L1797S, L1813S, L1820S, L1834S, L646S, L664S, L689S, L710S, L734S, L736S, L1670S, L1710S, L1711S, L1726S, L1768S, L1791S, L1819S, L1543S, L1685S, L1712S, L1727S, L1750S, L1755S, L1769S, L1790S, L1796S, L1798S, L1811S, L1812S, L1836S, L1838S, L608S, L623S, L647S, L648S, L654S, L665S, L668S, L687S, L691S, L697S, L709S, L971S, L1835S, L1859S, L1861S, L559S, L568S, L622S, L666S, L693S, L694S, L696S, L711S, L732S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091656	17	41197771	17	43045754	91656	97133	rs398122702	NC_000017.11:43045753:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5513T>A (p.Val1838Glu)	BRCA1	V1838E, V1859E, V734E, V1791E, V1669E, V1684E, V1749E, V1750E, V1771E, V1789E, V1795E, V1797E, V1812E, V1858E, V426E, V607E, V625E, V645E, V646E, V668E, V687E, V695E, V756E, V969E, V1541E, V1725E, V1766E, V1770E, V1790E, V1794E, V1811E, V1819E, V1836E, V1837E, V558E, V621E, V626E, V647E, V653E, V655E, V688E, V709E, V731E, V733E, V735E, V1542E, V1711E, V1726E, V1727E, V1767E, V1768E, V1769E, V1796E, V1833E, V1834E, V1860E, V567E, V664E, V686E, V693E, V710E, V757E, V970E, V1709E, V1710E, V1748E, V1754E, V1810E, V1818E, V1835E, V608E, V622E, V663E, V665E, V667E, V690E, V692E, V694E, V696E, V708E, V732E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055611	17	41197774	17	43045757	55611	70278	rs80357107	NC_000017.11:43045756:A:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5511G>C (p.Trp1837Cys)	BRCA1	W1837C, W1790C, W733C, W1858C, W1540C, W1709C, W1724C, W1753C, W1766C, W1788C, W1789C, W1796C, W1833C, W566C, W689C, W691C, W708C, W731C, W755C, W968C, W1541C, W1726C, W1748C, W1767C, W1795C, W1809C, W1817C, W1818C, W1857C, W1859C, W621C, W662C, W663C, W666C, W693C, W694C, W707C, W709C, W734C, W969C, W1668C, W1683C, W1725C, W1747C, W1770C, W1793C, W1810C, W1832C, W1835C, W645C, W646C, W664C, W695C, W732C, W756C, W1708C, W1710C, W1749C, W1765C, W1768C, W1769C, W1794C, W1811C, W1834C, W1836C, W425C, W557C, W606C, W607C, W620C, W624C, W625C, W644C, W652C, W654C, W667C, W685C, W686C, W687C, W692C, W730C	Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|not provided|Hereditary cancer-predisposing syndrome	VCV000421244	17	41197776	17	43045759	421244	409942	rs80356914	NC_000017.11:43045758:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5511G>T (p.Trp1837Cys)	BRCA1	W1837C, W1790C, W733C, W1858C, W1541C, W1708C, W1724C, W1725C, W1726C, W1768C, W1788C, W1793C, W1809C, W1811C, W1818C, W606C, W607C, W646C, W652C, W654C, W662C, W663C, W664C, W667C, W686C, W689C, W692C, W695C, W734C, W755C, W756C, W1709C, W1710C, W1748C, W1749C, W1789C, W1794C, W1795C, W1835C, W1857C, W566C, W624C, W694C, W968C, W1683C, W1747C, W1765C, W1766C, W1769C, W1833C, W1834C, W557C, W620C, W625C, W644C, W685C, W691C, W707C, W708C, W709C, W730C, W1540C, W1668C, W1753C, W1767C, W1770C, W1796C, W1810C, W1817C, W1832C, W1836C, W1859C, W425C, W621C, W645C, W666C, W687C, W693C, W731C, W732C, W969C	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000037680	17	41197776	17	43045759	37680	46236	rs80356914	NC_000017.11:43045758:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jan 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5509T>A (p.Trp1837Arg)	BRCA1	W1790R, W733R, W1837R, W1858R, W1540R, W1708R, W1725R, W1747R, W1748R, W1793R, W1795R, W1796R, W1811R, W1835R, W557R, W566R, W646R, W662R, W666R, W685R, W687R, W730R, W734R, W755R, W756R, W1541R, W1710R, W1726R, W1765R, W1766R, W1769R, W1770R, W1809R, W1817R, W1818R, W1859R, W625R, W645R, W664R, W667R, W689R, W692R, W694R, W969R, W1668R, W1683R, W1709R, W1724R, W1749R, W1753R, W1768R, W1788R, W1789R, W1833R, W1834R, W1836R, W621R, W644R, W686R, W695R, W708R, W968R, W663R, W691R, W693R, W707R, W709R, W731R, W732R, W1767R, W1794R, W1810R, W1832R, W1857R, W425R, W606R, W607R, W620R, W624R, W652R, W654R	not provided|Hereditary breast ovarian cancer syndrome	VCV000853483	17	41197778	17	43045761	853483	845361	rs80356959	NC_000017.11:43045760:A:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5509T>G (p.Trp1837Gly)	BRCA1	W1837G, W1790G, W1858G, W733G, W1541G, W1710G, W1725G, W1749G, W1753G, W1765G, W1768G, W1770G, W1789G, W606G, W624G, W625G, W689G, W691G, W693G, W707G, W730G, W731G, W732G, W755G, W1540G, W1708G, W1726G, W1747G, W1769G, W1788G, W1810G, W1811G, W1817G, W1834G, W1835G, W620G, W621G, W644G, W652G, W666G, W667G, W694G, W708G, W734G, W756G, W969G, W1683G, W1724G, W1766G, W1794G, W1796G, W1836G, W1857G, W607G, W663G, W664G, W686G, W687G, W692G, W709G, W1668G, W1709G, W1748G, W1767G, W1793G, W1795G, W1809G, W1818G, W1832G, W1833G, W1859G, W425G, W557G, W566G, W645G, W646G, W654G, W662G, W685G, W695G, W968G	BRCA1-related cancer predisposition	VCV000055607	17	41197778	17	43045761	55607	70274	rs80356959	NC_000017.11:43045760:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.5509T>C (p.Trp1837Arg)	BRCA1	W1837R, W733R, W1858R, W1790R, W1540R, W1541R, W1725R, W1747R, W1766R, W1768R, W1794R, W1817R, W425R, W621R, W624R, W625R, W646R, W662R, W663R, W685R, W691R, W707R, W731R, W1668R, W1683R, W1724R, W1765R, W1770R, W1789R, W1795R, W1796R, W1809R, W1810R, W1832R, W1857R, W1859R, W557R, W606R, W666R, W667R, W687R, W692R, W730R, W734R, W1708R, W1709R, W1710R, W1726R, W1767R, W1788R, W1818R, W1833R, W566R, W607R, W644R, W652R, W664R, W686R, W693R, W694R, W695R, W708R, W732R, W1748R, W1749R, W1753R, W1769R, W1793R, W1811R, W1834R, W1835R, W1836R, W620R, W645R, W654R, W689R, W709R, W755R, W756R, W968R, W969R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037679	17	41197778	17	43045761	37679	46235	rs80356959	NC_000017.11:43045760:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5497G>A (p.Val1833Met)	BRCA1	V1833M, V1854M, V729M, V1786M, V1536M, V1722M, V1745M, V1761M, V1763M, V1764M, V1765M, V1784M, V1790M, V1807M, V1828M, V1830M, V1831M, V1853M, V553M, V617M, V621M, V642M, V659M, V683M, V689M, V703M, V704M, V752M, V965M, V1537M, V1664M, V1679M, V1720M, V1721M, V1749M, V1813M, V1829M, V1855M, V603M, V640M, V660M, V726M, V964M, V1706M, V1743M, V1744M, V1785M, V1789M, V1806M, V1814M, V1832M, V421M, V602M, V616M, V650M, V663M, V682M, V727M, V751M, V1704M, V1705M, V1762M, V1766M, V1791M, V1792M, V1805M, V562M, V620M, V641M, V648M, V658M, V662M, V681M, V685M, V687M, V688M, V690M, V691M, V705M, V728M, V730M	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055598	17	41197790	17	43045773	55598	70265	rs80357268	NC_000017.11:43045772:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Dec 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5478G>C (p.Gln1826His)	BRCA1	Q722H, Q1779H, D698H, Q1847H, Q1826H, D1760H, D1800H, Q1529H, Q1715H, Q1737H, Q1738H, Q1755H, Q1777H, Q1783H, Q1784H, Q1799H, Q1800H, Q1806H, Q1822H, Q546H, Q555H, Q595H, Q633H, Q634H, Q635H, Q652H, Q680H, Q682H, Q696H, Q698H, Q719H, Q721H, Q957H, Q1759H, Q1798H, Q1807H, Q1821H, Q1824H, Q609H, Q613H, Q653H, Q681H, Q684H, Q720H, D1802H, Q1657H, Q1698H, Q1713H, Q1736H, Q1742H, Q1754H, Q1757H, Q1758H, D1754H, D1755H, D1801H, Q1530H, Q1697H, Q1699H, Q1778H, Q1782H, Q1825H, Q1846H, Q1848H, Q414H, Q610H, Q614H, Q655H, Q676H, Q723H, Q745H, Q958H, D1759H, D1761H, D697H, Q1672H, Q1714H, Q1756H, Q1785H, Q1823H, Q596H, Q641H, Q643H, Q651H, Q656H, Q674H, Q675H, Q678H, Q683H, Q697H, Q744H	Hereditary cancer-predisposing syndrome	VCV000864919	17	41197809	17	43045792	864919	853244	rs80357332	NC_000017.11:43045791:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Mar 19, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5476C>T (p.Gln1826Ter)	BRCA1	A697V, Q722*, Q1826*, Q1779*, Q1847*, A1758V, A1759V, A1760V, Q1657*, Q1713*, Q1715*, Q1742*, Q1757*, Q1758*, Q1782*, Q1825*, Q555*, Q595*, Q613*, Q633*, Q651*, Q653*, Q680*, Q681*, Q698*, Q958*, A1799V, A1801V, A696V, Q1530*, Q1697*, Q1698*, Q1699*, Q1714*, Q1737*, Q1798*, Q1806*, Q1821*, Q1822*, Q1848*, Q546*, Q610*, Q635*, Q652*, Q656*, Q674*, Q675*, Q678*, Q684*, Q696*, Q697*, Q723*, Q744*, Q1846*, Q609*, Q683*, Q719*, Q957*, A1754V, A1800V, Q1529*, Q1754*, Q1777*, Q1778*, Q1783*, Q1799*, Q1800*, Q1807*, Q1823*, Q414*, Q596*, Q614*, Q634*, Q641*, Q643*, Q655*, Q676*, Q682*, Q720*, Q721*, Q745*, A1753V, Q1672*, Q1736*, Q1738*, Q1755*, Q1756*, Q1759*, Q1784*, Q1785*, Q1824*	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000868969	17	41197811	17	43045794	868969	853247	rs587782887	NC_000017.11:43045793:G:A	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Oct 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5467G>T (p.Ala1823Ser)	BRCA1	A1844S, A1823S, A719S, A1776S, C694F, A1669S, A1695S, A1774S, A1779S, A1782S, A1818S, A1819S, A1820S, A1845S, A543S, A638S, A652S, A675S, A677S, A679S, A717S, A742S, C1755F, C693F, A1526S, A1696S, A1710S, A1734S, A1735S, A1795S, A1822S, A592S, A610S, A611S, A630S, A632S, A648S, A653S, A671S, A693S, A716S, A954S, C1757F, C1797F, A1527S, A1654S, A1694S, A1739S, A1753S, A1755S, A1756S, A1775S, A1796S, A1797S, A1803S, A1843S, A593S, A606S, A607S, A640S, A649S, A680S, A694S, A720S, C1751F, A1711S, A1712S, A1733S, A1751S, A1752S, A1754S, A1780S, A1781S, A1804S, A1821S, A411S, A552S, A631S, A650S, A672S, A673S, A678S, A681S, A695S, A718S, A741S, A955S, C1750F, C1756F, C1796F, C1798F	Hereditary cancer-predisposing syndrome	VCV000868922	17	41199660	17	43047643	868922	853268	rs80357212	NC_000017.11:43047642:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Apr 1, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5467G>A (p.Ala1823Thr)	BRCA1	A1823T, A1844T, A719T, A1776T, C694Y, A1526T, A1654T, A1696T, A1774T, A1775T, A1779T, A1818T, A1843T, A1845T, A632T, A640T, A653T, A671T, A677T, A680T, A694T, A717T, A1712T, A1735T, A1739T, A1753T, A1756T, A1781T, A1796T, A1803T, A1804T, A1820T, A593T, A606T, A638T, A650T, A652T, A672T, A673T, A695T, A718T, A741T, C1750Y, C1797Y, A1669T, A1694T, A1711T, A1752T, A1755T, A1780T, A1795T, A1797T, A592T, A607T, A610T, A630T, A631T, A648T, A675T, A678T, A679T, A720T, C1756Y, C1757Y, C1796Y, C1798Y, C693Y, A1527T, A1695T, A1710T, A1733T, A1734T, A1751T, A1754T, A1782T, A1819T, A1821T, A1822T, A411T, A543T, A552T, A611T, A649T, A681T, A693T, A716T, A742T, A954T, A955T, C1751Y, C1755Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055588	17	41199660	17	43047643	55588	70255	rs80357212	NC_000017.11:43047642:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jun 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5456A>G (p.Asn1819Ser)	BRCA1	N1819S, N1840S, N715S, N1772S, N1665S, N1692S, N1731S, N1748S, N1751S, N1776S, N1777S, N1792S, N1814S, N1839S, N407S, N539S, N589S, N626S, N628S, N636S, N644S, N667S, N668S, N675S, N676S, N712S, N713S, N716S, N738S, N950S, N951S, N1523S, N1691S, N1708S, N1729S, N1735S, N1749S, N1750S, N1800S, N1815S, N1817S, N602S, N606S, N673S, N674S, N677S, N690S, N1522S, N1690S, N1706S, N1730S, N1771S, N1778S, N1793S, N1816S, N548S, N588S, N603S, N607S, N645S, N648S, N649S, N737S, N1650S, N1707S, N1747S, N1752S, N1770S, N1775S, N1791S, N1799S, N1818S, N1841S, N627S, N634S, N646S, N669S, N671S, N689S, N691S, N714S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Familial pancreatic carcinoma|not provided|Hereditary breast ovarian cancer syndrome	VCV000055585	17	41199671	17	43047654	55585	70252	rs80357286	NC_000017.11:43047653:T:C	single nucleotide variant	missense variant|synonymous variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5453A>G (p.Asp1818Gly)	BRCA1	D1818G, D1839G, D714G, D1771G, D1664G, D1706G, D1746G, D1770G, D1775G, D1798G, D538G, D643G, D713G, D1522G, D1689G, D1690G, D1748G, D1749G, D1777G, D1791G, D1816G, D1838G, D1840G, D587G, D605G, D635G, D645G, D666G, D668G, D670G, D688G, D736G, D950G, D1521G, D1649G, D1705G, D1707G, D1728G, D1734G, D1750G, D1751G, D1769G, D1774G, D1799G, D1813G, D1814G, D602G, D606G, D625G, D626G, D647G, D648G, D674G, D690G, D711G, D712G, D737G, D1691G, D1729G, D1730G, D1747G, D1776G, D1790G, D1792G, D1815G, D1817G, D406G, D547G, D588G, D601G, D627G, D633G, D644G, D667G, D672G, D673G, D675G, D676G, D689G, D715G, D949G	Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|BRCA1-related cancer predisposition	VCV000037672	17	41199674	17	43047657	37672	46228	rs80357477	NC_000017.11:43047656:T:C	single nucleotide variant	missense variant|synonymous variant	Pathogenic/Likely pathogenic	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5449G>T (p.Glu1817Ter)	BRCA1	E1817*, R688I, E1770*, E713*, E1838*, E1704*, E1706*, E1745*, E1746*, E1769*, E1774*, E1775*, E1798*, E1815*, E1837*, E604*, E671*, E673*, E688*, E711*, E736*, E948*, R1749I, R1751I, R1791I, E1520*, E1690*, E1728*, E1729*, E1747*, E1773*, E1776*, E1789*, E1791*, E1797*, E1812*, E1816*, E586*, E587*, E601*, E625*, E634*, E642*, E647*, E666*, E689*, E712*, E714*, E735*, R1744I, R1792I, R687I, E1521*, E1663*, E1705*, E1727*, E1749*, E1813*, E600*, E632*, E643*, E644*, E646*, E665*, E672*, E675*, E949*, R1745I, E1648*, E1688*, E1689*, E1733*, E1748*, E1750*, E1768*, E1790*, E1814*, E1839*, E405*, E537*, E546*, E605*, E624*, E626*, E667*, E669*, E674*, E687*, E710*, R1750I, R1790I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055583	17	41199678	17	43047661	55583	70250	rs80356868	NC_000017.11:43047660:C:A	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5445G>A (p.Trp1815Ter)	BRCA1	W1815*, D687N, W1836*, W1768*, W711*, D1743N, D1750N, D1789N, W1518*, W1688*, W1726*, W1743*, W1744*, W1745*, W1771*, W1788*, W1812*, W1813*, W598*, W602*, W622*, W624*, W670*, W685*, W687*, W709*, D1744N, D1748N, W1703*, W1725*, W1766*, W1772*, W1789*, W1795*, W1810*, W1835*, W403*, W584*, W623*, W630*, W642*, W644*, W645*, W671*, W672*, W712*, W734*, D1791N, D686N, W1661*, W1727*, W1747*, W1767*, W1773*, W1796*, W1811*, W535*, W585*, W640*, W665*, W669*, W946*, D1749N, D1790N, W1519*, W1646*, W1686*, W1687*, W1702*, W1704*, W1731*, W1746*, W1748*, W1774*, W1787*, W1814*, W1837*, W544*, W599*, W603*, W632*, W641*, W663*, W664*, W667*, W673*, W686*, W708*, W710*, W733*, W947*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055581	17	41199682	17	43047665	55581	70248	rs397509284	NC_000017.11:43047664:C:T	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5434C>G (p.Pro1812Ala)	BRCA1	P1812A, A683G, P1833A, P1765A, P708A, A1744G, P1683A, P1685A, P1723A, P1724A, P1742A, P1743A, P1744A, P1786A, P1792A, P1808A, P1834A, P599A, P619A, P627A, P629A, P641A, P642A, P660A, P666A, P683A, P706A, P731A, P943A, P944A, A1739G, A1786G, A1787G, P1700A, P1701A, P1722A, P1728A, P1740A, P1768A, P1785A, P1807A, P1811A, P1832A, P532A, P582A, P595A, P596A, P620A, P637A, P662A, P669A, P670A, P682A, P705A, P707A, A1740G, A1745G, A682G, P1516A, P1643A, P1741A, P1764A, P1769A, P1771A, P1793A, P1810A, P581A, P621A, P638A, P639A, P664A, P684A, P709A, P730A, A1746G, A1785G, P1515A, P1658A, P1684A, P1699A, P1745A, P1763A, P1770A, P1784A, P1809A, P400A, P541A, P600A, P661A, P667A, P668A	Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided	VCV000037670	17	41199693	17	43047676	37670	46226	rs1800751	NC_000017.11:43047675:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Oct 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5431C>T (p.Gln1811Ter)	BRCA1	Q1811*, A682V, Q1764*, Q707*, Q1832*, A1738V, A1745V, A1784V, A681V, Q1515*, Q1642*, Q1657*, Q1684*, Q1700*, Q1727*, Q1740*, Q1742*, Q1768*, Q1785*, Q1791*, Q1809*, Q399*, A1785V, A1786V, Q1514*, Q1698*, Q1723*, Q1744*, Q1770*, Q1792*, Q1808*, Q1831*, Q540*, Q580*, Q595*, Q599*, Q618*, Q619*, Q637*, Q660*, Q683*, Q704*, Q729*, Q594*, Q626*, Q628*, Q659*, Q667*, Q668*, Q706*, Q942*, Q943*, A1743V, A1744V, Q1682*, Q1699*, Q1722*, Q1743*, Q1763*, Q1767*, Q1783*, Q1784*, Q1807*, Q1833*, Q581*, Q641*, Q665*, Q666*, Q669*, Q682*, Q705*, Q708*, A1739V, Q1683*, Q1721*, Q1739*, Q1741*, Q1762*, Q1769*, Q1806*, Q1810*, Q531*, Q598*, Q620*, Q636*, Q638*, Q640*, Q661*, Q663*, Q681*, Q730*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055577	17	41199696	17	43047679	55577	70244	rs397509283	NC_000017.11:43047678:G:A	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5411T>A (p.Val1804Asp)	BRCA1	V1804D, C675*, V1757D, V1825D, V700D, C1779*, V1676D, V1716D, V1720D, V1732D, V1735D, V1756D, V1761D, V1777D, V1785D, V1801D, V1824D, V574D, V613D, V630D, V631D, V675D, V699D, V935D, C1778*, V1507D, V1635D, V1675D, V1733D, V1734D, V1736D, V1737D, V1763D, V1800D, V1826D, V392D, V573D, V587D, V588D, V611D, V653D, V658D, V659D, V662D, V698D, V723D, C1731*, C674*, V1691D, V1692D, V1715D, V1760D, V1762D, V1776D, V1778D, V1784D, V524D, V591D, V612D, V619D, V621D, V629D, V634D, V656D, V661D, V674D, V936D, C1732*, C1736*, C1737*, C1738*, C1777*, V1508D, V1650D, V1677D, V1693D, V1714D, V1755D, V1799D, V1802D, V1803D, V533D, V592D, V633D, V652D, V654D, V660D, V676D, V697D, V701D, V722D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055568	17	41199716	17	43047699	55568	70235	rs80356920	NC_000017.11:43047698:A:T	single nucleotide variant	missense variant|nonsense|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5409T>C (p.Gly1803=)	BRCA1	C675R, C1731R, C1737R, C1738R, C674R, C1778R, C1779R, C1777R, C1732R, C1736R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000868463	17	41199718	17	43047701	868463	853393	rs2050995166	NC_000017.11:43047700:A:G	single nucleotide variant	synonymous variant|missense variant	Benign/Likely benign	Jan 19, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5408G>C (p.Gly1803Ala)	BRCA1	G1803A, G1824A, G699A, G1756A, G1506A, G1676A, G1714A, G1735A, G1761A, G1775A, G1776A, G1777A, G1799A, G1801A, G523A, G587A, G610A, G611A, G630A, G653A, G1507A, G1634A, G1691A, G1713A, G1715A, G1719A, G1731A, G1736A, G1760A, G1762A, G1784A, G1802A, G1825A, G532A, G612A, G632A, G651A, G652A, G660A, G935A, G657A, G661A, G673A, G674A, G698A, G700A, G721A, G722A, G1649A, G1675A, G1692A, G1732A, G1733A, G1800A, G586A, G591A, G633A, G655A, G658A, G659A, G697A, G934A, G1674A, G1690A, G1734A, G1754A, G1755A, G1759A, G1783A, G1798A, G1823A, G391A, G572A, G573A, G590A, G618A, G620A, G628A, G629A, G675A, G696A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000037668	17	41199719	17	43047702	37668	46224	rs80357149	NC_000017.11:43047701:C:G	single nucleotide variant	missense variant|synonymous variant	Pathogenic/Likely pathogenic	Dec 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5359_5363delinsAGTGA (p.Cys1787_Gly1788delinsSerAsp)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000187349	17	41201181 - 41201185	17	43049164 - 43049168	187349	184875	rs786203663	NC_000017.11:43049163:CCACA:TCACT	Indel	missense variant|non-coding transcript variant|intron variant	Pathogenic	Mar 25, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5363G>T (p.Gly1788Val)	BRCA1	G1788V, G1741V, G1809V, G684V, G1619V, G1677V, G1717V, G1739V, G1491V, G1634V, G1660V, G1718V, G1746V, G1768V, G1783V, G1786V, G1808V, G376V, G517V, G558V, G576V, G617V, G618V, G643V, G658V, G683V, G706V, G1492V, G1659V, G1661V, G1700V, G1719V, G1720V, G1740V, G571V, G595V, G597V, G613V, G614V, G637V, G638V, G640V, G642V, G644V, G685V, G920V, G1675V, G1676V, G1698V, G1699V, G1716V, G1721V, G1744V, G1747V, G1762V, G1785V, G1787V, G557V, G572V, G575V, G596V, G615V, G645V, G646V, G660V, G682V, G919V, G1745V, G1760V, G1761V, G1769V, G1784V, G1810V, G508V, G603V, G605V, G636V, G659V, G681V, G707V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037660	17	41201181	17	43049164	37660	46216	rs80357069	NC_000017.11:43049163:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NC_000017.10:g.[41201181C>T;41201185A>T]	BRCA1	C1787S, C1740S, C1808S, C683S, C1698S, C1699S, C1717S, C1719S, C1739S, C1744S, C1745S, C1759S, C1767S, C1783S, C571S, C602S, C604S, C614S, C616S, C636S, C645S, C684S, C705S, C706S, C1491S, C1618S, C1633S, C1660S, C1674S, C1715S, C1716S, C1720S, C1761S, C1782S, C1785S, C1786S, C516S, C570S, C574S, C595S, C617S, C682S, C919S, C1658S, C1659S, C1676S, C1697S, C1738S, C1746S, C1760S, C1784S, C1807S, C375S, C556S, C596S, C612S, C613S, C635S, C637S, C639S, C641S, C642S, C644S, C658S, C680S, C1490S, C1675S, C1718S, C1743S, C1768S, C1809S, C507S, C557S, C575S, C594S, C643S, C657S, C659S, C681S, C918S, G1788D, G684D, G1809D, G1741D, G1491D, G1676D, G1698D, G1717D, G1718D, G1761D, G1769D, G1785D, G508D, G557D, G572D, G595D, G605D, G636D, G638D, G645D, G658D, G660D, G682D, G706D, G1492D, G1619D, G1634D, G1659D, G1740D, G1744D, G1747D, G1760D, G1762D, G1768D, G1787D, G376D, G596D, G603D, G614D, G618D, G637D, G642D, G644D, G646D, G659D, G681D, G683D, G1660D, G1661D, G1677D, G1700D, G1719D, G1720D, G1784D, G1786D, G1808D, G1810D, G571D, G597D, G613D, G617D, G640D, G707D, G919D, G920D, G1675D, G1699D, G1716D, G1721D, G1739D, G1745D, G1746D, G1783D, G517D, G558D, G575D, G576D, G615D, G643D, G685D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000624568	17|17	41201185	17|17	43049168	624568	70215|70218	rs80357065|rs80357069	NC_000017.11:43049167:A:T|NC_000017.11:43049163:C:T	Haplotype	missense variant|non-coding transcript variant|intron variant	Pathogenic	Mar 25, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5347A>T (p.Met1783Leu)	BRCA1	M679L, M1736L, M1783L, M1804L, M1486L, M1654L, M1670L, M1671L, M1712L, M1715L, M1741L, M1757L, M1763L, M503L, M512L, M552L, M567L, M609L, M637L, M640L, M677L, M1629L, M1672L, M1693L, M1713L, M1714L, M1734L, M1739L, M1778L, M1781L, M1782L, M1803L, M600L, M612L, M613L, M632L, M638L, M653L, M655L, M676L, M915L, M1614L, M1656L, M1695L, M1711L, M1740L, M1779L, M1805L, M553L, M571L, M590L, M591L, M592L, M608L, M633L, M635L, M639L, M680L, M702L, M1487L, M1655L, M1694L, M1716L, M1735L, M1742L, M1755L, M1756L, M1764L, M1780L, M371L, M566L, M570L, M598L, M610L, M631L, M641L, M654L, M678L, M701L, M914L	Hereditary breast ovarian cancer syndrome	VCV000865370	17	41201197	17	43049180	865370	853523	rs80357012	NC_000017.11:43049179:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Benign	Jul 20, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5339T>C (p.Leu1780Pro)	BRCA1	L1780P, L676P, L1733P, L1801P, L1484P, L1653P, L1667P, L1668P, L1692P, L1711P, L1712P, L1713P, L1731P, L1732P, L500P, L509P, L589P, L605P, L606P, L607P, L609P, L628P, L634P, L650P, L698P, L699P, L911P, L1483P, L1611P, L1669P, L1691P, L1708P, L1738P, L1739P, L1761P, L1775P, L1779P, L1800P, L368P, L550P, L588P, L595P, L636P, L652P, L674P, L677P, L1709P, L1736P, L1752P, L1753P, L1754P, L1777P, L1778P, L564P, L567P, L587P, L610P, L637P, L638P, L651P, L675P, L912P, L1626P, L1651P, L1652P, L1690P, L1710P, L1737P, L1760P, L1776P, L1802P, L549P, L563P, L568P, L597P, L629P, L630P, L632P, L635P, L673P	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Hereditary breast ovarian cancer syndrome	VCV000055541	17	41201205	17	43049188	55541	70208	rs80357474	NC_000017.11:43049187:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5332G>A (p.Asp1778Asn)	BRCA1	D1778N, D1731N, G674R, D1799N, D674N, D1609N, D1624N, D1651N, D1689N, D1690N, D1710N, D1736N, D1759N, D1773N, D1774N, D1800N, D498N, D547N, D562N, D593N, D604N, D608N, D627N, D628N, D634N, D673N, D696N, D697N, G1736R, G1776R, G673R, D1482N, D1665N, D1666N, D1709N, D1711N, D1734N, D1737N, D1752N, D1775N, D1777N, D366N, D548N, D561N, D585N, D587N, D595N, D607N, D632N, D636N, D675N, G1737R, D1481N, D1688N, D1707N, D1708N, D1758N, D1776N, D603N, D649N, D671N, D909N, G1731R, G1778R, D1649N, D1650N, D1667N, D1706N, D1729N, D1730N, D1735N, D1750N, D1751N, D1798N, D507N, D565N, D566N, D586N, D605N, D626N, D630N, D633N, D635N, D648N, D650N, D672N, D910N, G1730R, G1735R, G1777R	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055530	17	41203080	17	43051063	55530	70197	rs80357112	NC_000017.11:43051062:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jun 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5324T>A (p.Met1775Lys)	BRCA1	M1775K, M1728K, M671K, M1796K, M1479K, M1647K, M1685K, M1704K, M1756K, M363K, M544K, M562K, M582K, M625K, M627K, M630K, M668K, M694K, M907K, M1664K, M1686K, M1726K, M1731K, M1732K, M1733K, M1771K, M1773K, M504K, M545K, M592K, M601K, M906K, M1606K, M1646K, M1648K, M1663K, M1687K, M1706K, M1708K, M1727K, M1734K, M1748K, M1755K, M1795K, M495K, M558K, M559K, M563K, M583K, M602K, M604K, M624K, M647K, M669K, M670K, M693K, M1478K, M1621K, M1662K, M1703K, M1705K, M1707K, M1747K, M1749K, M1770K, M1772K, M1774K, M1797K, M584K, M590K, M600K, M605K, M623K, M629K, M631K, M632K, M633K, M645K, M646K, M672K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017695	17	41203088	17	43051071	17695	32734	rs41293463	NC_000017.11:43051070:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5324T>G (p.Met1775Arg)	BRCA1	M1775R, M1728R, M1796R, M671R, M1478R, M1647R, M1663R, M1686R, M1703R, M1704R, M1727R, M1733R, M1771R, M1773R, M1795R, M363R, M504R, M562R, M583R, M584R, M600R, M602R, M625R, M631R, M632R, M633R, M645R, M670R, M693R, M906R, M907R, M1648R, M1664R, M1706R, M1734R, M1749R, M1770R, M1772R, M1774R, M1797R, M558R, M559R, M582R, M604R, M629R, M630R, M668R, M672R, M1479R, M1606R, M1662R, M1687R, M1705R, M1707R, M1708R, M1726R, M1731R, M1732R, M1755R, M495R, M592R, M627R, M647R, M669R, M694R, M1621R, M1646R, M1685R, M1747R, M1748R, M1756R, M544R, M545R, M563R, M590R, M601R, M605R, M623R, M624R, M646R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017694	17	41203088	17	43051071	17694	32733	rs41293463	NC_000017.11:43051070:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5309G>T (p.Gly1770Val)	BRCA1	G1770V, G1791V, G1723V, G666V, G1474V, G1601V, G1616V, G1641V, G1658V, G1698V, G1727V, G1792V, G490V, G539V, G554V, G577V, G585V, G587V, G596V, G618V, G626V, G627V, G663V, G665V, G901V, G1657V, G1680V, G1681V, G1701V, G1722V, G1729V, G1742V, G1744V, G1766V, G1769V, G499V, G540V, G558V, G579V, G619V, G622V, G628V, G902V, G1659V, G1682V, G1700V, G1726V, G1728V, G1743V, G1750V, G1765V, G1768V, G1790V, G358V, G553V, G600V, G620V, G625V, G641V, G664V, G688V, G1473V, G1642V, G1643V, G1699V, G1702V, G1703V, G1721V, G1751V, G1767V, G557V, G578V, G595V, G597V, G599V, G624V, G640V, G642V, G667V, G689V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000417832	17	41203103	17	43051086	417832	404710	rs863224765	NC_000017.11:43051085:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jul 18, 2018	reviewed by expert panel							
NM_007294.4(BRCA1):c.5297T>A (p.Ile1766Asn)	BRCA1	I1766N, I662N, I1787N, I1719N, I1470N, I1597N, I1637N, I1638N, I1639N, I1676N, I1678N, I1694N, I1696N, I1722N, I1725N, I1740N, I1764N, I1765N, I1788N, I354N, I495N, I549N, I573N, I581N, I583N, I592N, I595N, I596N, I616N, I660N, I685N, I1653N, I1698N, I1718N, I1724N, I1747N, I1761N, I1763N, I536N, I553N, I591N, I593N, I622N, I624N, I636N, I637N, I638N, I684N, I1612N, I1654N, I1655N, I1697N, I1699N, I1723N, I1746N, I1762N, I486N, I535N, I550N, I575N, I615N, I621N, I661N, I898N, I1469N, I1677N, I1695N, I1717N, I1738N, I1739N, I1786N, I554N, I574N, I614N, I618N, I620N, I623N, I659N, I663N, I897N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267594	17	41203115	17	43051098	267594	262926	rs80357463	NC_000017.11:43051097:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5297T>G (p.Ile1766Ser)	BRCA1	I1766S, I1719S, I662S, I1787S, I1637S, I1638S, I1678S, I1697S, I1699S, I1722S, I1747S, I1765S, I495S, I574S, I591S, I592S, I595S, I615S, I616S, I620S, I623S, I637S, I663S, I685S, I897S, I1597S, I1612S, I1653S, I1694S, I1723S, I1724S, I1725S, I1762S, I1786S, I536S, I553S, I554S, I573S, I581S, I614S, I659S, I661S, I684S, I1470S, I1639S, I1677S, I1698S, I1717S, I1738S, I1740S, I1761S, I1788S, I354S, I486S, I535S, I549S, I583S, I593S, I596S, I618S, I624S, I636S, I638S, I898S, I1469S, I1654S, I1655S, I1676S, I1695S, I1696S, I1718S, I1739S, I1746S, I1763S, I1764S, I550S, I575S, I621S, I622S, I660S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037656	17	41203115	17	43051098	37656	46212	rs80357463	NC_000017.11:43051097:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5291T>C (p.Leu1764Pro)	BRCA1	L1764P, L1717P, L660P, L1785P, L1468P, L1610P, L1635P, L1651P, L1694P, L1736P, L1745P, L1760P, L1784P, L484P, L571P, L594P, L618P, L622P, L635P, L658P, L661P, L896P, L1467P, L1636P, L1637P, L1676P, L1693P, L1695P, L1697P, L1721P, L1723P, L1737P, L1744P, L1786P, L352P, L534P, L572P, L579P, L581P, L590P, L593P, L657P, L682P, L1595P, L1652P, L1653P, L1674P, L1692P, L1696P, L1715P, L1716P, L1759P, L1761P, L1763P, L552P, L589P, L612P, L613P, L619P, L621P, L634P, L636P, L895P, L1675P, L1720P, L1722P, L1738P, L1762P, L493P, L533P, L547P, L548P, L551P, L573P, L591P, L614P, L616P, L620P, L659P, L683P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055510	17	41203121	17	43051104	55510	70177	rs80357281	NC_000017.11:43051103:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5259A>C (p.Arg1753Ser)	BRCA1	R649S, R1774S, R1706S, R1753S, R1457S, R1640S, R1642S, R1665S, R1683S, R1686S, R1709S, R1726S, R1727S, R1749S, R1775S, R473S, R482S, R536S, R560S, R579S, R582S, R672S, R561S, R568S, R578S, R583S, R602S, R603S, R610S, R611S, R648S, R650S, R885S, R1584S, R1624S, R1626S, R1681S, R1682S, R1725S, R1748S, R1751S, R341S, R522S, R540S, R562S, R570S, R580S, R601S, R605S, R608S, R609S, R623S, R624S, R646S, R647S, R1733S, R1752S, R1773S, R537S, R541S, R1456S, R1641S, R1663S, R1685S, R1704S, R1705S, R1710S, R1599S, R1625S, R1664S, R1684S, R1711S, R1712S, R1734S, R1750S, R523S, R607S, R625S, R671S, R884S	Hereditary breast ovarian cancer syndrome	VCV000865211	17	41209087	17	43057070	865211	853687	rs771577266	NC_000017.11:43057069:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Apr 29, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5258G>C (p.Arg1753Thr)	BRCA1	R1753T, R1774T, R1706T, R649T, R1625T, R1686T, R1709T, R1751T, R1773T, R560T, R562T, R570T, R580T, R582T, R583T, R607T, R610T, R611T, R624T, R646T, R671T, R672T, R1456T, R1584T, R1624T, R1626T, R1641T, R1642T, R1681T, R1685T, R1704T, R1705T, R1710T, R1711T, R1725T, R1727T, R1748T, R1775T, R341T, R482T, R523T, R540T, R541T, R578T, R609T, R647T, R648T, R884T, R885T, R1640T, R1663T, R1664T, R1683T, R1712T, R473T, R536T, R537T, R561T, R601T, R602T, R603T, R605T, R623T, R625T, R650T, R1457T, R1599T, R1665T, R1682T, R1684T, R1726T, R1733T, R1734T, R1749T, R1750T, R1752T, R522T, R568T, R579T, R608T	Hereditary breast ovarian cancer syndrome|not provided	VCV000055488	17	41209088	17	43057071	55488	70155	rs397509246	NC_000017.11:43057070:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5255C>A (p.Ala1752Glu)	BRCA1	A1705E, A1752E, A1773E, A648E, A1623E, A1625E, A1639E, A1641E, A1680E, A1682E, A1709E, A1711E, A1726E, A1733E, A340E, A472E, A560E, A561E, A567E, A582E, A601E, A624E, A646E, A647E, A1662E, A1663E, A1683E, A1684E, A1704E, A1708E, A1751E, A535E, A559E, A607E, A622E, A671E, A883E, A1456E, A1583E, A1624E, A1640E, A1664E, A1732E, A1747E, A1748E, A1749E, A481E, A522E, A536E, A540E, A569E, A578E, A579E, A602E, A604E, A606E, A623E, A670E, A884E, A1455E, A1598E, A1681E, A1685E, A1703E, A1710E, A1724E, A1725E, A1750E, A1772E, A1774E, A521E, A539E, A577E, A581E, A600E, A608E, A609E, A610E, A645E, A649E	Hereditary cancer-predisposing syndrome	VCV000868230	17	41209091	17	43057074	868230	853693	rs80357028	NC_000017.11:43057073:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Dec 15, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5254G>C (p.Ala1752Pro)	BRCA1	A1752P, A648P, A1705P, A1773P, A1639P, A1640P, A1641P, A1683P, A1703P, A1708P, A1725P, A1732P, A1748P, A1750P, A481P, A522P, A535P, A560P, A601P, A608P, A610P, A670P, A884P, A1455P, A1624P, A1625P, A1662P, A1680P, A1682P, A1704P, A1710P, A472P, A539P, A540P, A569P, A577P, A578P, A582P, A604P, A609P, A622P, A646P, A883P, A1583P, A1598P, A1664P, A1684P, A1709P, A1724P, A1726P, A1747P, A1751P, A1772P, A581P, A600P, A602P, A607P, A623P, A649P, A671P, A1456P, A1623P, A1663P, A1681P, A1685P, A1711P, A1733P, A1749P, A1774P, A340P, A521P, A536P, A559P, A561P, A567P, A579P, A606P, A624P, A645P, A647P	Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000055483	17	41209092	17	43057075	55483	70150	rs80357074	NC_000017.11:43057074:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5252G>A (p.Arg1751Gln)	BRCA1	R1751Q, R1704Q, R1772Q, R647Q, R1455Q, R1639Q, R1662Q, R1680Q, R1681Q, R1710Q, R1747Q, R1771Q, R1773Q, R539Q, R559Q, R580Q, R600Q, R601Q, R623Q, R646Q, R669Q, R1582Q, R1623Q, R1624Q, R1661Q, R1679Q, R1684Q, R1708Q, R1709Q, R1732Q, R1746Q, R1750Q, R339Q, R471Q, R560Q, R576Q, R599Q, R603Q, R609Q, R644Q, R882Q, R1454Q, R1597Q, R1682Q, R1703Q, R1723Q, R1748Q, R480Q, R534Q, R577Q, R578Q, R581Q, R605Q, R606Q, R621Q, R648Q, R883Q, R1622Q, R1638Q, R1640Q, R1663Q, R1683Q, R1702Q, R1707Q, R1724Q, R1725Q, R1731Q, R1749Q, R520Q, R521Q, R535Q, R538Q, R558Q, R566Q, R568Q, R607Q, R608Q, R622Q, R645Q, R670Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055481	17	41209094	17	43057077	55481	70148	rs80357442	NC_000017.11:43057076:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5246C>G (p.Pro1749Arg)	BRCA1	P1749R, P1702R, P1770R, P645R, P1636R, P1661R, P1700R, P1706R, P1723R, P533R, P574R, P606R, P607R, P644R, P646R, P880R, P881R, P1637R, P1638R, P1659R, P1677R, P1679R, P1705R, P1708R, P1721R, P1729R, P1746R, P1769R, P1771R, P518R, P519R, P537R, P557R, P575R, P578R, P597R, P598R, P604R, P619R, P643R, P1580R, P1595R, P1621R, P1678R, P1681R, P1701R, P1745R, P1748R, P532R, P556R, P558R, P579R, P601R, P603R, P620R, P642R, P1452R, P1453R, P1620R, P1622R, P1660R, P1680R, P1682R, P1707R, P1722R, P1730R, P1744R, P1747R, P337R, P469R, P478R, P536R, P564R, P566R, P576R, P599R, P605R, P621R, P667R, P668R	not provided	VCV000055479	17	41209100	17	43057083	55479	70146	rs80357462	NC_000017.11:43057082:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jan 2, 2014	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5243G>A (p.Gly1748Asp)	BRCA1	G1748D, G644D, G1701D, G1769D, G1579D, G1636D, G1677D, G1707D, G1720D, G1721D, G1729D, G1743D, G1744D, G1746D, G468D, G532D, G575D, G577D, G603D, G619D, G620D, G642D, G666D, G1452D, G1619D, G1678D, G1681D, G1700D, G1704D, G1745D, G1768D, G336D, G518D, G535D, G563D, G565D, G573D, G600D, G605D, G606D, G643D, G645D, G667D, G1635D, G1660D, G1679D, G1722D, G1728D, G1747D, G1770D, G531D, G536D, G555D, G578D, G598D, G641D, G879D, G1451D, G1594D, G1620D, G1621D, G1637D, G1658D, G1659D, G1676D, G1680D, G1699D, G1705D, G1706D, G477D, G517D, G556D, G557D, G574D, G596D, G597D, G602D, G604D, G618D, G880D	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000055476	17	41209103	17	43057086	55476	70143	rs397509243	NC_000017.11:43057085:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5216A>T (p.Asp1739Val)	BRCA1	D1739V, D1692V, D635V, D1760V, D1585V, D1611V, D1649V, D1650V, D1669V, D1671V, D1695V, D1697V, D1719V, D1734V, D1737V, D1761V, D327V, D459V, D468V, D509V, D526V, D547V, D556V, D564V, D594V, D596V, D610V, D658V, D1570V, D1612V, D1626V, D1667V, D1668V, D1672V, D1690V, D1691V, D1713V, D1736V, D527V, D565V, D566V, D568V, D589V, D593V, D597V, D609V, D634V, D871V, D1442V, D1610V, D1628V, D1670V, D1698V, D1720V, D508V, D523V, D546V, D548V, D569V, D587V, D632V, D636V, D595V, D611V, D633V, D657V, D870V, D1443V, D1627V, D1651V, D1696V, D1711V, D1712V, D1735V, D1738V, D1759V, D522V, D554V, D588V, D591V	Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055466	17	41209130	17	43057113	55466	70133	rs80357227	NC_000017.11:43057112:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jun 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5216A>G (p.Asp1739Gly)	BRCA1	D1739G, D1760G, D1692G, D635G, D1442G, D1570G, D1610G, D1612G, D1691G, D1696G, D1711G, D1719G, D1735G, D1759G, D1761G, D547G, D566G, D568G, D588G, D610G, D633G, D634G, D657G, D658G, D870G, D871G, D1626G, D1651G, D1667G, D1671G, D1672G, D1713G, D1720G, D1734G, D1736G, D468G, D522G, D523G, D565G, D596G, D597G, D609G, D632G, D1443G, D1611G, D1628G, D1649G, D1650G, D1669G, D1670G, D1697G, D1737G, D509G, D526G, D546G, D554G, D556G, D564G, D589G, D591G, D594G, D1585G, D1627G, D1668G, D1690G, D1695G, D1698G, D1712G, D1738G, D327G, D459G, D508G, D527G, D548G, D569G, D587G, D593G, D595G, D611G, D636G	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055465	17	41209130	17	43057113	55465	70132	rs80357227	NC_000017.11:43057112:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5213G>T (p.Gly1738Val)	BRCA1	G1691V, G1759V, G1738V, G634V, G1609V, G1648V, G1667V, G1670V, G1690V, G1710V, G1711V, G1719V, G1736V, G1760V, G507V, G522V, G546V, G568V, G592V, G595V, G635V, G657V, G870V, G1441V, G1442V, G1611V, G1627V, G1668V, G1669V, G1671V, G1689V, G1696V, G1697V, G1735V, G1737V, G467V, G508V, G526V, G553V, G588V, G594V, G596V, G608V, G609V, G610V, G633V, G656V, G1569V, G1610V, G1626V, G1712V, G1718V, G326V, G525V, G545V, G555V, G567V, G590V, G631V, G1584V, G1625V, G1649V, G1650V, G1666V, G1694V, G1695V, G1733V, G1734V, G1758V, G458V, G521V, G547V, G563V, G564V, G565V, G586V, G587V, G593V, G632V, G869V	Hereditary breast ovarian cancer syndrome	VCV000845528	17	41209133	17	43057116	845528	845369	rs80357450	NC_000017.11:43057115:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jan 30, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5213G>A (p.Gly1738Glu)	BRCA1	G1738E, G1691E, G1759E, G634E, G1569E, G1610E, G1626E, G1627E, G1649E, G1710E, G1711E, G1733E, G1760E, G522E, G546E, G590E, G593E, G1609E, G1625E, G1666E, G1667E, G1670E, G1689E, G1690E, G1694E, G1735E, G1758E, G458E, G467E, G521E, G526E, G553E, G555E, G587E, G596E, G609E, G635E, G869E, G870E, G1442E, G1611E, G1650E, G1669E, G1696E, G1697E, G1712E, G1718E, G1734E, G1736E, G326E, G564E, G567E, G586E, G588E, G594E, G595E, G633E, G656E, G657E, G1441E, G1584E, G1648E, G1668E, G1671E, G1695E, G1719E, G1737E, G507E, G508E, G525E, G545E, G547E, G563E, G565E, G568E, G592E, G608E, G610E, G631E, G632E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000055462	17	41209133	17	43057116	55462	70129	rs80357450	NC_000017.11:43057115:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5212G>C (p.Gly1738Arg)	BRCA1	G1759R, G634R, G1738R, G1691R, G1442R, G1584R, G1626R, G1627R, G1670R, G1690R, G1694R, G1696R, G1719R, G1733R, G458R, G508R, G525R, G526R, G546R, G567R, G586R, G590R, G596R, G632R, G633R, G656R, G657R, G870R, G1441R, G1609R, G1610R, G1667R, G1669R, G1689R, G1695R, G1710R, G1711R, G1718R, G1734R, G1735R, G1758R, G326R, G553R, G555R, G564R, G588R, G608R, G610R, G631R, G1611R, G1625R, G1666R, G1671R, G1697R, G1712R, G1760R, G467R, G507R, G522R, G547R, G563R, G565R, G568R, G587R, G593R, G594R, G609R, G635R, G869R, G1569R, G1648R, G1649R, G1650R, G1668R, G1736R, G1737R, G521R, G545R, G592R, G595R	Hereditary cancer-predisposing syndrome	VCV000865165	17	41209134	17	43057117	865165	853771	rs80356937	NC_000017.11:43057116:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	May 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5212G>A (p.Gly1738Arg)	BRCA1	G1738R, G1691R, G634R, G1759R, G1442R, G1609R, G1610R, G1611R, G1666R, G1670R, G1689R, G1696R, G1710R, G1719R, G1733R, G1734R, G326R, G522R, G525R, G526R, G553R, G555R, G563R, G592R, G608R, G609R, G610R, G635R, G869R, G1441R, G1584R, G1626R, G1648R, G1649R, G1669R, G1694R, G1695R, G1711R, G1712R, G1718R, G467R, G546R, G564R, G567R, G594R, G595R, G596R, G631R, G632R, G657R, G1667R, G1690R, G1697R, G1736R, G1737R, G521R, G565R, G586R, G587R, G593R, G1569R, G1625R, G1627R, G1650R, G1668R, G1671R, G1735R, G1758R, G1760R, G458R, G507R, G508R, G545R, G547R, G568R, G588R, G590R, G633R, G656R, G870R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055461	17	41209134	17	43057117	55461	70128	rs80356937	NC_000017.11:43057116:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5207T>G (p.Val1736Gly)	BRCA1	V1736G, V1757G, V1689G, V632G, V1439G, V1625G, V1647G, V1687G, V1688G, V1692G, V1708G, V1709G, V1710G, V1731G, V1734G, V1735G, V324G, V456G, V506G, V524G, V562G, V585G, V1567G, V1608G, V1624G, V1665G, V1666G, V1668G, V1716G, V1733G, V519G, V543G, V544G, V553G, V565G, V591G, V592G, V606G, V629G, V633G, V867G, V868G, V1609G, V1623G, V1648G, V1664G, V1667G, V1669G, V1693G, V1717G, V1758G, V465G, V523G, V545G, V551G, V566G, V584G, V586G, V593G, V607G, V631G, V654G, V1440G, V1582G, V1607G, V1646G, V1694G, V1695G, V1732G, V1756G, V505G, V520G, V561G, V563G, V588G, V590G, V594G, V608G, V630G, V655G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055456	17	41209139	17	43057122	55456	70123	rs45553935	NC_000017.11:43057121:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5207T>C (p.Val1736Ala)	BRCA1	V1736A, V1757A, V632A, V1689A, V1567A, V1582A, V1607A, V1624A, V1646A, V1664A, V1668A, V1692A, V1695A, V1716A, V1733A, V1735A, V1756A, V519A, V520A, V545A, V551A, V561A, V562A, V588A, V591A, V593A, V655A, V1439A, V1440A, V1609A, V1623A, V1647A, V1665A, V1669A, V1687A, V1688A, V1693A, V1708A, V324A, V506A, V524A, V543A, V565A, V594A, V606A, V608A, V630A, V631A, V654A, V868A, V1608A, V1666A, V1667A, V1694A, V1709A, V1717A, V1758A, V456A, V465A, V505A, V523A, V544A, V563A, V584A, V629A, V1625A, V1648A, V1710A, V1731A, V1732A, V1734A, V553A, V566A, V585A, V586A, V590A, V592A, V607A, V633A, V867A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037648	17	41209139	17	43057122	37648	46204	rs45553935	NC_000017.11:43057121:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jun 25, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5198A>G (p.Asp1733Gly)	BRCA1	D1733G, D1754G, D629G, D1686G, D1564G, D1604G, D1645G, D1661G, D1665G, D1684G, D1692G, D1705G, D1706G, D1728G, D502G, D517G, D550G, D581G, D603G, D605G, D626G, D1436G, D1605G, D1606G, D1644G, D1662G, D1664G, D1691G, D1714G, D1730G, D1732G, D503G, D542G, D548G, D562G, D585G, D587G, D627G, D1437G, D1579G, D1620G, D1643G, D1663G, D1685G, D1690G, D1713G, D1729G, D1731G, D453G, D462G, D520G, D559G, D560G, D563G, D582G, D589G, D630G, D652G, D865G, D1621G, D1622G, D1666G, D1689G, D1707G, D1753G, D1755G, D321G, D516G, D521G, D540G, D541G, D558G, D583G, D588G, D590G, D591G, D604G, D628G, D651G, D864G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055453	17	41209148	17	43057131	55453	70120	rs80357270	NC_000017.11:43057130:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5158A>G (p.Thr1720Ala)	BRCA1	T1720A, T616A, T1673A, T1741A, T1423A, T1630A, T1648A, T1649A, T1650A, T1652A, T1653A, T1672A, T1679A, T1716A, T1718A, T1742A, T308A, T440A, T503A, T504A, T508A, T546A, T549A, T617A, T1424A, T1566A, T1591A, T1592A, T1608A, T1700A, T1717A, T489A, T490A, T529A, T572A, T576A, T590A, T1609A, T1631A, T1651A, T1676A, T1677A, T1678A, T1692A, T1701A, T1715A, T527A, T537A, T547A, T550A, T568A, T575A, T591A, T592A, T615A, T638A, T639A, T851A, T852A, T1551A, T1593A, T1607A, T1632A, T1671A, T1693A, T1694A, T1719A, T1740A, T449A, T507A, T528A, T535A, T545A, T569A, T570A, T574A, T577A, T578A, T613A, T614A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055438	17	41215385	17	43063368	55438	70105	rs56195342	NC_000017.11:43063367:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5154G>C (p.Trp1718Cys)	BRCA1	W1718C, W1739C, W614C, W1671C, W1422C, W1549C, W1564C, W1605C, W1606C, W1648C, W1651C, W1669C, W1691C, W1699C, W1714C, W1716C, W438C, W533C, W535C, W547C, W568C, W573C, W575C, W611C, W1590C, W1591C, W1629C, W1646C, W1677C, W306C, W488C, W525C, W543C, W570C, W589C, W590C, W615C, W850C, W1421C, W1628C, W1630C, W1647C, W1649C, W1670C, W1674C, W1676C, W1698C, W1715C, W1717C, W1738C, W1740C, W487C, W505C, W506C, W526C, W548C, W566C, W567C, W576C, W588C, W612C, W613C, W636C, W1589C, W1607C, W1675C, W1690C, W1692C, W1713C, W447C, W501C, W502C, W527C, W544C, W545C, W572C, W574C, W637C, W849C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865068	17	41215389	17	43063372	865068	853883	rs80357239	NC_000017.11:43063371:C:G	single nucleotide variant	missense variant|synonymous variant|non-coding transcript variant	Pathogenic		criteria provided, single submitter							
NM_007294.4(BRCA1):c.5154G>T (p.Trp1718Cys)	BRCA1	W1718C, W1671C, W1739C, W614C, W1422C, W1564C, W1628C, W1629C, W1647C, W1648C, W1670C, W1677C, W1699C, W1738C, W306C, W488C, W506C, W525C, W535C, W548C, W568C, W590C, W613C, W1549C, W1589C, W1607C, W1651C, W1669C, W1674C, W1691C, W1713C, W1740C, W501C, W533C, W544C, W547C, W567C, W573C, W576C, W615C, W849C, W1421C, W1590C, W1605C, W1606C, W1675C, W1690C, W1714C, W1715C, W1716C, W1717C, W487C, W505C, W526C, W527C, W545C, W570C, W572C, W588C, W612C, W636C, W1591C, W1630C, W1646C, W1649C, W1676C, W1692C, W1698C, W438C, W447C, W502C, W543C, W566C, W574C, W575C, W589C, W611C, W637C, W850C	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055435	17	41215389	17	43063372	55435	70102	rs80357239	NC_000017.11:43063371:C:A	single nucleotide variant	missense variant|non-coding transcript variant|synonymous variant	Pathogenic/Likely pathogenic	Dec 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5153G>A (p.Trp1718Ter)	BRCA1	W1718*, W1739*, W1671*, W614*, W1549*, W1590*, W1605*, W1647*, W1675*, W1677*, W1691*, W1699*, W1714*, W1717*, W447*, W501*, W502*, W505*, W535*, W548*, W570*, W572*, W573*, W589*, W612*, W637*, G1692E, W1421*, W1564*, W1589*, W1606*, W1646*, W1648*, W1670*, W1674*, W1690*, W1738*, W1740*, W306*, W438*, W506*, W525*, W543*, W547*, W566*, W588*, W613*, W615*, W849*, W1607*, W1628*, W1629*, W1630*, W1669*, W1676*, W1692*, W1698*, W1713*, W1715*, W1716*, W487*, W488*, W526*, W527*, W545*, W568*, W574*, W575*, W590*, W611*, W636*, W850*, G1650E, W1422*, W1591*, W1649*, W1651*, W533*, W544*, W567*, W576*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055432	17	41215390	17	43063373	55432	70099	rs41293461	NC_000017.11:43063372:C:T	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5145C>G (p.Ser1715Arg)	BRCA1	S1715R, S1736R, S611R, S1668R, S1546R, S1602R, S1604R, S1627R, S1666R, S1687R, S1689R, S303R, S435R, S484R, S502R, S523R, S532R, S571R, S573R, S634R, S1586R, S1625R, S1644R, S1648R, S1673R, S1695R, S1696R, S1710R, S1735R, S498R, S499R, S503R, S1418R, S1419R, S1561R, S1603R, S1646R, S1667R, S1672R, S1674R, S1688R, S1711R, S1713R, S1737R, S485R, S563R, S567R, S570R, S572R, S585R, S586R, S633R, S1587R, S1588R, S1626R, S1643R, S1645R, S1671R, S1712R, S1714R, S444R, S524R, S530R, S541R, S564R, S565R, S587R, S609R, S610R, S612R, S522R, S540R, S542R, S544R, S545R, S569R, S608R, S846R, S847R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055418	17	41215898	17	43063881	55418	70085	rs80357094	NC_000017.11:43063880:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Oct 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5144G>A (p.Ser1715Asn)	BRCA1	S1715N, S1736N, S1668N, S611N, S1418N, S1604N, S1626N, S1648N, S1672N, S1687N, S1689N, S1695N, S1713N, S1735N, S1737N, S444N, S484N, S485N, S498N, S523N, S564N, S565N, S571N, S573N, S587N, S610N, S633N, S846N, S1419N, S1586N, S1587N, S1588N, S1603N, S1643N, S1644N, S1645N, S1666N, S1667N, S1673N, S1674N, S1688N, S1696N, S1710N, S303N, S503N, S532N, S540N, S542N, S563N, S585N, S586N, S609N, S847N, S1546N, S1561N, S1625N, S1627N, S1711N, S541N, S544N, S545N, S567N, S569N, S608N, S612N, S1602N, S1646N, S1671N, S1712N, S1714N, S435N, S499N, S502N, S522N, S524N, S530N, S570N, S572N, S634N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055416	17	41215899	17	43063882	55416	70083	rs45444999	NC_000017.11:43063881:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5143A>T (p.Ser1715Cys)	BRCA1	S1715C, S1736C, S611C, S1668C, S1546C, S1561C, S1666C, S1689C, S1710C, S1714C, S1737C, S444C, S498C, S502C, S503C, S530C, S545C, S565C, S572C, S573C, S587C, S610C, S612C, S634C, S846C, S1418C, S1588C, S1604C, S1625C, S1626C, S1644C, S1671C, S1688C, S1695C, S1712C, S1713C, S1735C, S484C, S499C, S523C, S544C, S569C, S570C, S586C, S608C, S609C, S1419C, S1586C, S1602C, S1603C, S1667C, S1672C, S1674C, S1687C, S1711C, S435C, S485C, S522C, S524C, S540C, S541C, S564C, S585C, S633C, S847C, S1587C, S1627C, S1643C, S1645C, S1646C, S1648C, S1673C, S1696C, S303C, S532C, S542C, S563C, S567C, S571C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000055415	17	41215900	17	43063883	55415	70082	rs80357222	NC_000017.11:43063882:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5143A>C (p.Ser1715Arg)	BRCA1	S1715R, S1668R, S611R, S1736R, S1419R, S1561R, S1586R, S1587R, S1643R, S1644R, S1689R, S1696R, S1714R, S303R, S498R, S523R, S542R, S544R, S571R, S585R, S633R, S846R, S1602R, S1625R, S1626R, S1648R, S1666R, S1667R, S1671R, S1672R, S1687R, S1688R, S1713R, S1737R, S484R, S499R, S524R, S530R, S541R, S565R, S634R, S1418R, S1546R, S1588R, S1603R, S1627R, S1645R, S1673R, S1695R, S1711R, S1712R, S444R, S502R, S503R, S532R, S540R, S545R, S567R, S569R, S573R, S587R, S610R, S612R, S847R, S1604R, S1646R, S1674R, S1710R, S1735R, S435R, S485R, S522R, S563R, S564R, S570R, S572R, S586R, S608R, S609R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055414	17	41215900	17	43063883	55414	70081	rs80357222	NC_000017.11:43063882:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5141T>G (p.Val1714Gly)	BRCA1	V1714G, V610G, V1667G, V1735G, V1603G, V1643G, V1644G, V1647G, V1665G, V1713G, V1736G, V434G, V498G, V531G, V566G, V568G, V607G, V846G, V1417G, V1642G, V1673G, V1687G, V1709G, V1712G, V1734G, V302G, V483G, V484G, V501G, V523G, V529G, V543G, V544G, V562G, V564G, V569G, V571G, V584G, V608G, V611G, V1418G, V1585G, V1586G, V1602G, V1624G, V1626G, V1645G, V1666G, V1672G, V1686G, V1694G, V1710G, V1711G, V443G, V497G, V502G, V522G, V541G, V570G, V572G, V585G, V586G, V845G, V540G, V563G, V609G, V632G, V633G, V1545G, V1560G, V1587G, V1601G, V1625G, V1670G, V1671G, V1688G, V1695G, V521G, V539G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast neoplasm|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055413	17	41215902	17	43063885	55413	70080	rs80357243	NC_000017.11:43063884:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5138_5139delinsGG (p.Val1713Gly)	BRCA1	V1417G, V1585G, V1623G, V1642G, V1644G, V1664G, V1672G, V1708G, V1734G, V433G, V442G, V483G, V538G, V543G, V561G, V562G, V609G, V631G, V632G, V845G, V1641G, V1646G, V1670G, V1686G, V1687G, V1710G, V1712G, V1735G, V482G, V497G, V540G, V542G, V565G, V567G, V568G, V569G, V571G, V585G, V608G, V844G, V1544G, V1584G, V1600G, V1624G, V1625G, V1665G, V1666G, V1671G, V1685G, V1709G, V1711G, V301G, V501G, V522G, V528G, V539G, V563G, V570G, V583G, V607G, V610G, V1416G, V1559G, V1586G, V1601G, V1602G, V1643G, V1669G, V1693G, V1694G, V1713G, V1733G, V496G, V500G, V520G, V521G, V530G, V584G, V606G	Hereditary cancer-predisposing syndrome	VCV001745580	17	41215904 - 41215905	17	43063887 - 43063888	1745580	1802632		NC_000017.11:43063886:TA:CC	Indel	missense variant|non-coding transcript variant	Pathogenic	Oct 6, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5138T>G (p.Val1713Gly)	BRCA1	V1666G, V1713G, V1734G, V609G, V1417G, V1601G, V1602G, V1624G, V1625G, V1643G, V1670G, V1687G, V1693G, V301G, V501G, V521G, V530G, V538G, V542G, V570G, V583G, V608G, V632G, V1586G, V1623G, V1665G, V1671G, V1685G, V1694G, V1708G, V1710G, V1712G, V1735G, V483G, V496G, V500G, V522G, V528G, V539G, V540G, V561G, V569G, V571G, V584G, V606G, V845G, V1416G, V1544G, V1585G, V1600G, V1641G, V1642G, V1672G, V1686G, V497G, V565G, V567G, V568G, V610G, V1559G, V1584G, V1644G, V1646G, V1664G, V1669G, V1709G, V1711G, V1733G, V433G, V442G, V482G, V520G, V543G, V562G, V563G, V585G, V607G, V631G, V844G	Hereditary cancer-predisposing syndrome	VCV000868702	17	41215905	17	43063888	868702	853908	rs80357132	NC_000017.11:43063887:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 20, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5123C>A (p.Ala1708Glu)	BRCA1	A1708E, A1661E, A1729E, A604E, A1580E, A1618E, A1619E, A1638E, A1659E, A1411E, A1539E, A1595E, A1641E, A1660E, A1666E, A1688E, A1730E, A437E, A478E, A495E, A535E, A538E, A562E, A564E, A566E, A578E, A627E, A1554E, A1579E, A1581E, A1596E, A1620E, A1636E, A1664E, A1681E, A428E, A496E, A517E, A525E, A533E, A563E, A579E, A601E, A605E, A839E, A1667E, A1704E, A1705E, A1706E, A477E, A515E, A516E, A557E, A560E, A580E, A603E, A626E, A1412E, A1597E, A1637E, A1639E, A1665E, A1680E, A1682E, A1689E, A1703E, A1707E, A1728E, A296E, A491E, A492E, A523E, A534E, A537E, A556E, A558E, A565E, A602E, A840E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055407	17	41215920	17	43063903	55407	70074	rs28897696	NC_000017.11:43063902:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5117G>C (p.Gly1706Ala)	BRCA1	G1706A, G1659A, G602A, G1727A, G1409A, G1595A, G1665A, G1703A, G426A, G435A, G489A, G493A, G494A, G521A, G523A, G555A, G556A, G558A, G560A, G576A, G578A, G599A, G838A, G1552A, G1577A, G1616A, G1617A, G1634A, G1636A, G1637A, G1658A, G1679A, G1680A, G1686A, G1704A, G294A, G514A, G564A, G600A, G624A, G1594A, G1639A, G1657A, G1663A, G1678A, G1702A, G1705A, G513A, G535A, G561A, G562A, G563A, G601A, G603A, G625A, G837A, G1410A, G1537A, G1578A, G1579A, G1593A, G1618A, G1635A, G1662A, G1664A, G1687A, G1701A, G1726A, G1728A, G475A, G476A, G490A, G515A, G531A, G532A, G533A, G536A, G554A, G577A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055406	17	41215926	17	43063909	55406	70073	rs80356860	NC_000017.11:43063908:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5117G>A (p.Gly1706Glu)	BRCA1	G1706E, G1727E, G1659E, G602E, G1577E, G1593E, G1595E, G1617E, G1636E, G1637E, G1657E, G1658E, G1663E, G1664E, G1665E, G1678E, G1679E, G1686E, G1703E, G435E, G475E, G476E, G490E, G514E, G515E, G523E, G532E, G536E, G554E, G563E, G578E, G599E, G601E, G1409E, G1634E, G1635E, G1701E, G1702E, G1726E, G493E, G531E, G533E, G555E, G561E, G562E, G576E, G1410E, G1537E, G1578E, G1616E, G1639E, G1662E, G1687E, G1705E, G426E, G489E, G521E, G558E, G560E, G564E, G600E, G624E, G625E, G1552E, G1579E, G1594E, G1618E, G1680E, G1704E, G1728E, G294E, G494E, G513E, G535E, G556E, G577E, G603E, G837E, G838E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037638	17	41215926	17	43063909	37638	46194	rs80356860	NC_000017.11:43063908:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5116G>A (p.Gly1706Arg)	BRCA1	G1706R, G1659R, G1727R, G602R, G1537R, G1579R, G1593R, G1634R, G1662R, G1678R, G1687R, G1728R, G476R, G513R, G514R, G523R, G531R, G532R, G558R, G578R, G600R, G601R, G837R, G1410R, G1577R, G1594R, G1616R, G1617R, G1636R, G1637R, G1658R, G1664R, G1665R, G1702R, G426R, G435R, G490R, G554R, G560R, G564R, G599R, G603R, G838R, G1552R, G1595R, G1618R, G1657R, G1663R, G1679R, G1703R, G294R, G493R, G535R, G555R, G556R, G563R, G577R, G1409R, G1578R, G1635R, G1639R, G1680R, G1686R, G1701R, G1704R, G1705R, G1726R, G475R, G489R, G494R, G515R, G521R, G533R, G536R, G561R, G562R, G576R, G624R, G625R	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000267221	17	41215927	17	43063910	267221	262101	rs886040864	NC_000017.11:43063909:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5116G>C (p.Gly1706Arg)	BRCA1	G1706R, G1659R, G1727R, G602R, G1410R, G1578R, G1593R, G1595R, G1635R, G1657R, G1663R, G1687R, G1703R, G1704R, G1728R, G476R, G490R, G513R, G514R, G532R, G533R, G536R, G561R, G577R, G578R, G625R, G837R, G838R, G1537R, G1577R, G1594R, G1634R, G1636R, G1662R, G1664R, G1665R, G1678R, G1686R, G1701R, G1705R, G475R, G489R, G521R, G555R, G560R, G562R, G603R, G624R, G1552R, G1616R, G1639R, G1679R, G1702R, G294R, G426R, G435R, G494R, G535R, G554R, G556R, G558R, G563R, G564R, G1409R, G1579R, G1617R, G1618R, G1637R, G1658R, G1680R, G1726R, G493R, G515R, G523R, G531R, G576R, G599R, G600R, G601R	Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000267219	17	41215927	17	43063910	267219	262100	rs886040864	NC_000017.11:43063909:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 13, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5114T>C (p.Leu1705Pro)	BRCA1	L624P, L836P, L837P, L1705P, L1726P, L601P, L1658P, L1577P, L1578P, L1594P, L1635P, L1656P, L1661P, L1703P, L425P, L520P, L531P, L532P, L599P, L600P, L623P, L1592P, L1593P, L1615P, L1616P, L1634P, L1638P, L1664P, L1677P, L1686P, L1701P, L1704P, L475P, L488P, L493P, L513P, L534P, L557P, L559P, L560P, L562P, L576P, L602P, L1408P, L1409P, L1536P, L1617P, L1633P, L1657P, L1678P, L1679P, L1702P, L1725P, L1727P, L293P, L474P, L489P, L512P, L553P, L554P, L575P, L577P, L1551P, L1576P, L1636P, L1662P, L1663P, L1685P, L1700P, L434P, L492P, L514P, L522P, L530P, L535P, L555P, L561P, L563P, L598P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000037637	17	41215929	17	43063912	37637	46193	rs397507242	NC_000017.11:43063911:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5096G>A (p.Arg1699Gln)	BRCA1	R1699Q, R1652Q, R595Q, R1720Q, R1572Q, R1611Q, R1627Q, R1657Q, R1671Q, R1672Q, R1698Q, R1721Q, R287Q, R469Q, R516Q, R529Q, R547Q, R548Q, R555Q, R556Q, R557Q, R569Q, R592Q, R593Q, R617Q, R1402Q, R1571Q, R1587Q, R1651Q, R1656Q, R1680Q, R1697Q, R506Q, R525Q, R528Q, R549Q, R553Q, R570Q, R618Q, R830Q, R1530Q, R1570Q, R1586Q, R1588Q, R1610Q, R1629Q, R1630Q, R1650Q, R1658Q, R1679Q, R1695Q, R1719Q, R419Q, R428Q, R468Q, R482Q, R486Q, R514Q, R524Q, R554Q, R596Q, R831Q, R1403Q, R1545Q, R1609Q, R1628Q, R1632Q, R1655Q, R1673Q, R1694Q, R1696Q, R483Q, R487Q, R507Q, R508Q, R526Q, R551Q, R571Q, R594Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037636	17	41215947	17	43063930	37636	46192	rs41293459	NC_000017.11:43063929:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	May 10, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5095C>T (p.Arg1699Trp)	BRCA1	R1699W, R595W, R1720W, R1652W, R1572W, R1630W, R1651W, R1655W, R1673W, R1694W, R1719W, R287W, R487W, R506W, R524W, R526W, R529W, R547W, R551W, R553W, R592W, R594W, R830W, R1570W, R1627W, R1658W, R1680W, R1696W, R1721W, R469W, R482W, R483W, R486W, R514W, R516W, R528W, R556W, R596W, R617W, R525W, R549W, R554W, R555W, R557W, R570W, R593W, R1402W, R1403W, R1545W, R1586W, R1588W, R1611W, R1629W, R1650W, R1657W, R1672W, R1697W, R1698W, R428W, R1530W, R1571W, R1587W, R1609W, R1610W, R1628W, R1632W, R1656W, R1671W, R1679W, R1695W, R419W, R468W, R507W, R508W, R548W, R569W, R571W, R618W, R831W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055396	17	41215948	17	43063931	55396	70063	rs55770810	NC_000017.11:43063930:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5089T>C (p.Cys1697Arg)	BRCA1	C1697R, C1650R, C593R, C1718R, C1401R, C1586R, C1607R, C1608R, C1609R, C1649R, C1653R, C1656R, C1670R, C1677R, C1695R, C1696R, C285R, C504R, C512R, C555R, C590R, C592R, C1568R, C1570R, C1626R, C1693R, C1694R, C1719R, C426R, C467R, C506R, C522R, C523R, C524R, C527R, C547R, C549R, C552R, C553R, C567R, C591R, C1400R, C1543R, C1584R, C1585R, C1628R, C1648R, C1654R, C1692R, C480R, C484R, C485R, C505R, C546R, C551R, C554R, C568R, C569R, C594R, C828R, C829R, C1528R, C1569R, C1625R, C1627R, C1630R, C1655R, C1669R, C1671R, C1678R, C1717R, C417R, C466R, C481R, C514R, C526R, C545R, C615R, C616R	BRCA1-related cancer predisposition	VCV000055392	17	41215954	17	43063937	55392	70059	rs80356993	NC_000017.11:43063936:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.5083T>G (p.Phe1695Val)	BRCA1	F1695V, F591V, F1716V, F1648V, F614V, F827V, F1583V, F1605V, F1625V, F1647V, F1669V, F1675V, F1676V, F1690V, F1691V, F483V, F502V, F520V, F525V, F550V, F551V, F552V, F588V, F1568V, F1582V, F1607V, F1624V, F1628V, F1652V, F1668V, F479V, F482V, F521V, F544V, F590V, F1398V, F1399V, F1566V, F1567V, F1584V, F1626V, F1653V, F1654V, F1667V, F1693V, F1694V, F464V, F503V, F510V, F512V, F524V, F543V, F545V, F547V, F549V, F565V, F566V, F567V, F592V, F613V, F826V, F1526V, F1541V, F1606V, F1623V, F1646V, F1651V, F1692V, F1715V, F1717V, F283V, F415V, F424V, F465V, F478V, F504V, F522V, F553V, F589V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869009	17	41215960	17	43063943	869009	854010	rs2051934276	NC_000017.11:43063942:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic		no assertion criteria provided							
NM_007294.4(BRCA1):c.5074G>T (p.Asp1692Tyr)	BRCA1	D1692Y, D1645Y, D1713Y, D588Y, D1396Y, D1538Y, D1602Y, D1604Y, D1621Y, D1622Y, D1650Y, D1651Y, D1664Y, D1666Y, D1673Y, D1689Y, D421Y, D476Y, D499Y, D501Y, D518Y, D519Y, D522Y, D542Y, D546Y, D548Y, D549Y, D610Y, D1564Y, D1603Y, D1620Y, D1643Y, D1648Y, D1665Y, D1688Y, D461Y, D462Y, D500Y, D509Y, D521Y, D547Y, D550Y, D563Y, D586Y, D824Y, G1692W, D1579Y, D1623Y, D1625Y, D1672Y, D1690Y, D1714Y, D412Y, D540Y, D562Y, D564Y, D589Y, D611Y, D823Y, D1395Y, D1523Y, D1563Y, D1565Y, D1580Y, D1581Y, D1644Y, D1649Y, D1687Y, D1691Y, D1712Y, D475Y, D479Y, D480Y, D507Y, D517Y, D541Y, D544Y, D585Y, D587Y, G1650W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055376	17	41219625	17	43067608	55376	70043	rs80187739	NC_000017.11:43067607:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5074G>C (p.Asp1692His)	BRCA1	D1692H, D1713H, D588H, D1645H, D1620H, D1621H, D1625H, D1664H, D1672H, D1688H, D1690H, D1712H, D412H, D479H, D500H, D501H, D507H, D521H, D542H, D546H, D610H, D611H, D824H, D1395H, D1563H, D1565H, D1579H, D1581H, D1648H, D1666H, D462H, D1564H, D1580H, D1622H, D1644H, D1651H, D1687H, D421H, D461H, D480H, D499H, D517H, D540H, D562H, D587H, D589H, D1538H, D1602H, D1603H, D1604H, D1623H, D1643H, D1649H, D1650H, D1665H, D1673H, D1689H, D1691H, D1714H, D475H, D549H, D564H, D585H, D586H, D823H, D1396H, D1523H, D476H, D509H, D518H, D519H, D522H, D541H, D544H, D547H, D548H, D550H, D563H, G1650R, G1692R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037633	17	41219625	17	43067608	37633	46189	rs80187739	NC_000017.11:43067607:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074G>A (p.Asp1692Asn)	BRCA1	D1692N, D1645N, D1713N, D588N, D1620N, D1648N, D1649N, D1650N, D1665N, D412N, D421N, D462N, D479N, D521N, D541N, D542N, D544N, D546N, D547N, D563N, D586N, D611N, D1523N, D1564N, D1565N, D1581N, D1603N, D1623N, D1673N, D1689N, D1691N, D500N, D519N, D540N, D549N, D550N, D562N, D564N, D587N, D823N, G1692R, D1395N, D1563N, D1579N, D1602N, D1622N, D1651N, D1664N, D1666N, D1687N, D1712N, D475N, D499N, D509N, D517N, D548N, D585N, G1650R, D1396N, D1538N, D1580N, D1604N, D1621N, D1625N, D1643N, D1644N, D1672N, D1688N, D1690N, D1714N, D461N, D476N, D480N, D501N, D507N, D518N, D522N, D589N, D610N, D824N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037632	17	41219625	17	43067608	37632	46188	rs80187739	NC_000017.11:43067607:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5072C>T (p.Thr1691Ile)	BRCA1	T1691I, T1712I, T1644I, T587I, T1395I, T1619I, T1620I, T1649I, T1650I, T1664I, T1672I, T1686I, T1688I, T1689I, T1711I, T1713I, T420I, T506I, T508I, T541I, T545I, T547I, T585I, T588I, T1522I, T1563I, T1602I, T1624I, T411I, T500I, T540I, T609I, T610I, T1394I, T1579I, T1601I, T1603I, T1621I, T1643I, T1647I, T1648I, T1663I, T1665I, T1690I, T460I, T474I, T475I, T478I, T499I, T517I, T518I, T521I, T543I, T548I, T586I, T823I, T1537I, T1562I, T1564I, T1578I, T1580I, T1622I, T1642I, T1671I, T1687I, T461I, T479I, T498I, T516I, T520I, T539I, T546I, T549I, T561I, T562I, T563I, T584I, T822I	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000037628	17	41219627	17	43067610	37628	46184	rs80357034	NC_000017.11:43067609:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5072C>A (p.Thr1691Lys)	BRCA1	T1691K, T1644K, T1712K, T587K, T1394K, T1537K, T1563K, T1579K, T1601K, T1621K, T1643K, T1648K, T1650K, T1671K, T1672K, T1711K, T420K, T478K, T518K, T521K, T543K, T548K, T584K, T585K, T822K, T1562K, T1564K, T1578K, T1602K, T1642K, T1647K, T1664K, T1687K, T1688K, T1689K, T1690K, T474K, T499K, T517K, T520K, T547K, T562K, T586K, T823K, T1395K, T1522K, T1580K, T1622K, T1663K, T1713K, T475K, T479K, T498K, T539K, T545K, T546K, T549K, T609K, T1603K, T1619K, T1620K, T1624K, T1649K, T1665K, T1686K, T411K, T460K, T461K, T500K, T506K, T508K, T516K, T540K, T541K, T561K, T563K, T588K, T610K	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	VCV000037627	17	41219627	17	43067610	37627	46183	rs80357034	NC_000017.11:43067609:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Sep 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5066T>G (p.Met1689Arg)	BRCA1	M1689R, M1642R, M585R, M1710R, M1393R, M1560R, M1562R, M1576R, M1599R, M1619R, M1646R, M1648R, M1663R, M1669R, M1670R, M1709R, M418R, M473R, M504R, M541R, M559R, M560R, M586R, M1600R, M1620R, M1661R, M1711R, M409R, M458R, M459R, M476R, M498R, M506R, M516R, M538R, M543R, M546R, M607R, M821R, M1392R, M1535R, M1561R, M1577R, M1640R, M1641R, M1645R, M1662R, M1687R, M1688R, M472R, M477R, M497R, M514R, M537R, M539R, M545R, M584R, M608R, M820R, M1520R, M1578R, M1601R, M1617R, M1618R, M1622R, M1647R, M1684R, M1685R, M1686R, M496R, M515R, M518R, M519R, M544R, M547R, M561R, M582R, M583R	BRCA1-related disorder|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided	VCV000037625	17	41219633	17	43067616	37625	46181	rs80357061	NC_000017.11:43067615:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5058T>A (p.His1686Gln)	BRCA1	H1686Q, H1639Q, H582Q, H1707Q, H511Q, H512Q, H515Q, H534Q, H535Q, H542Q, H581Q, H817Q, H818Q, H1390Q, H1532Q, H1557Q, H1574Q, H1614Q, H1616Q, H1642Q, H1644Q, H1645Q, H1682Q, H1684Q, H1708Q, H406Q, H473Q, H474Q, H493Q, H516Q, H541Q, H543Q, H556Q, H583Q, H1597Q, H1598Q, H1617Q, H1637Q, H1643Q, H1658Q, H1659Q, H1667Q, H1683Q, H456Q, H470Q, H503Q, H536Q, H538Q, H544Q, H558Q, H1596Q, H1619Q, H1638Q, H1666Q, H1681Q, H1706Q, H415Q, H455Q, H469Q, H495Q, H1389Q, H1517Q, H1558Q, H1559Q, H1573Q, H1575Q, H1615Q, H1660Q, H1685Q, H494Q, H501Q, H513Q, H540Q, H557Q, H579Q, H580Q, H604Q, H605Q	Hereditary breast ovarian cancer syndrome	VCV000055366	17	41219641	17	43067624	55366	70033	rs397509218	NC_000017.11:43067623:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	May 3, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5057A>G (p.His1686Arg)	BRCA1	H1686R, H582R, H1707R, H1639R, H1684R, H406R, H455R, H474R, H495R, H511R, H512R, H513R, H516R, H535R, H604R, H817R, H1575R, H1597R, H1598R, H1615R, H1638R, H1642R, H1644R, H1389R, H1559R, H1614R, H1645R, H1658R, H1681R, H1708R, H503R, H540R, H541R, H556R, H557R, H579R, H580R, H818R, H1390R, H1517R, H1558R, H1573R, H1574R, H1596R, H1617R, H1643R, H1659R, H1660R, H1682R, H1685R, H1706R, H493R, H501R, H536R, H538R, H542R, H543R, H558R, H583R, H1532R, H1557R, H1616R, H1619R, H1637R, H1666R, H1667R, H1683R, H415R, H456R, H469R, H470R, H473R, H494R, H515R, H534R, H544R, H581R, H605R	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Inherited ovarian cancer (without breast cancer)	VCV000183179	17	41219642	17	43067625	183179	181314	rs730882166	NC_000017.11:43067624:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5054C>T (p.Thr1685Ile)	BRCA1	T1685I, T1638I, T1706I, T581I, T1531I, T1557I, T1574I, T1595I, T1613I, T1659I, T1684I, T1705I, T405I, T493I, T494I, T533I, T556I, T579I, T1558I, T1572I, T1596I, T1597I, T1616I, T1618I, T1641I, T1643I, T1657I, T1658I, T1666I, T1680I, T1707I, T455I, T468I, T472I, T500I, T510I, T514I, T515I, T534I, T543I, T555I, T557I, T1516I, T1614I, T1636I, T1642I, T1665I, T1682I, T1683I, T454I, T511I, T512I, T535I, T539I, T578I, T582I, T603I, T604I, T816I, T1389I, T1388I, T1556I, T1573I, T1615I, T1637I, T1644I, T1681I, T414I, T469I, T473I, T492I, T502I, T537I, T540I, T541I, T542I, T580I, T817I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055365	17	41219645	17	43067628	55365	70032	rs80357043	NC_000017.11:43067627:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5053A>G (p.Thr1685Ala)	BRCA1	T1685A, T1638A, T581A, T1706A, T1558A, T1574A, T1615A, T1618A, T1642A, T1657A, T1658A, T1682A, T1684A, T493A, T502A, T556A, T816A, T1531A, T1572A, T1597A, T1616A, T1636A, T1644A, T1665A, T1681A, T1683A, T405A, T454A, T469A, T511A, T537A, T540A, T541A, T578A, T579A, T582A, T603A, T604A, T1388A, T1389A, T1556A, T1573A, T1596A, T1613A, T1637A, T1641A, T1659A, T1680A, T1707A, T414A, T455A, T468A, T492A, T494A, T514A, T515A, T533A, T534A, T543A, T555A, T557A, T1516A, T1557A, T1595A, T1614A, T1643A, T1666A, T1705A, T472A, T473A, T500A, T510A, T512A, T535A, T539A, T542A, T580A, T817A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055364	17	41219646	17	43067629	55364	70031	rs80356890	NC_000017.11:43067628:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5044G>A (p.Glu1682Lys)	BRCA1	E1682K, E1635K, E1703K, E578K, E1513K, E1569K, E1594K, E1610K, E1613K, E1656K, E1662K, E1663K, E1678K, E1679K, E1702K, E402K, E1385K, E1553K, E1592K, E1634K, E1638K, E1639K, E1640K, E1654K, E1704K, E452K, E489K, E490K, E491K, E497K, E512K, E530K, E537K, E540K, E553K, E813K, E1386K, E1555K, E1571K, E1633K, E1655K, E1677K, E1680K, E1681K, E451K, E507K, E531K, E532K, E575K, E576K, E411K, E466K, E499K, E508K, E538K, E552K, E554K, E579K, E600K, E1528K, E1554K, E1570K, E1593K, E1611K, E1612K, E1615K, E1641K, E465K, E469K, E470K, E509K, E511K, E534K, E536K, E539K, E577K, E601K, E814K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055361	17	41219655	17	43067638	55361	70028	rs80356958	NC_000017.11:43067637:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5024C>T (p.Thr1675Ile)	BRCA1	T1675I, T1696I, T1628I, T571I, T1506I, T1521I, T1562I, T1586I, T1606I, T1627I, T1631I, T1647I, T1648I, T1697I, T444I, T445I, T459I, T462I, T463I, T530I, T547I, T807I, T1563I, T1587I, T1603I, T1632I, T1649I, T1656I, T1674I, T1695I, T395I, T482I, T483I, T484I, T492I, T501I, T523I, T525I, T531I, T533I, T546I, T568I, T594I, T1378I, T1379I, T1546I, T1548I, T1585I, T1604I, T1605I, T1608I, T1626I, T1633I, T1634I, T1670I, T1671I, T1672I, T1673I, T490I, T502I, T545I, T569I, T572I, T593I, T1547I, T1564I, T1655I, T404I, T458I, T500I, T504I, T505I, T524I, T527I, T529I, T532I, T570I, T806I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000240811	17	41219675	17	43067658	240811	242767	rs150729791	NC_000017.11:43067657:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4991T>C (p.Leu1664Pro)	BRCA1	L1664P, L1685P, L1617P, L560P, L1368P, L1510P, L1615P, L1622P, L1659P, L1684P, L1686P, L384P, L447P, L452P, L472P, L491P, L493P, L512P, L513P, L559P, L561P, L582P, L583P, L1495P, L1537P, L1593P, L1620P, L1637P, L1638P, L1661P, L1662P, L393P, L434P, L479P, L481P, L494P, L520P, L534P, L535P, L536P, L796P, L1535P, L1574P, L1576P, L1592P, L1594P, L1597P, L1623P, L1663P, L473P, L490P, L516P, L519P, L522P, L557P, L558P, L795P, L1367P, L1536P, L1551P, L1552P, L1553P, L1575P, L1595P, L1616P, L1621P, L1636P, L1644P, L1645P, L1660P, L433P, L448P, L451P, L471P, L489P, L514P, L518P, L521P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037621	17	41219708	17	43067691	37621	46177	rs80357314	NC_000017.11:43067690:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4985T>C (p.Phe1662Ser)	BRCA1	F1662S, F558S, F1615S, F1683S, F1621S, F1636S, F1657S, F1659S, F1661S, F469S, F470S, F477S, F512S, F519S, F520S, F532S, F555S, F1366S, F1549S, F1574S, F1592S, F1618S, F1508S, F1550S, F1572S, F1573S, F1591S, F1595S, F1619S, F1643S, F391S, F445S, F446S, F489S, F514S, F516S, F517S, F534S, F581S, F793S, F1365S, F1493S, F1590S, F1593S, F1613S, F1614S, F1642S, F1660S, F1682S, F382S, F431S, F449S, F471S, F479S, F487S, F488S, F492S, F510S, F518S, F533S, F557S, F1533S, F1534S, F1535S, F1551S, F1620S, F1634S, F1635S, F1658S, F1684S, F432S, F450S, F491S, F511S, F556S, F559S, F580S, F794S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055339	17	41222946	17	43070929	55339	70006	rs28897695	NC_000017.11:43070928:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4964C>T (p.Ser1655Phe)	BRCA1	S1655F, S1676F, S551F, S1608F, S1358F, S1526F, S1567F, S1654F, S384F, S439F, S463F, S481F, S482F, S485F, S507F, S509F, S512F, S525F, S550F, S574F, S442F, S443F, S462F, S470F, S472F, S484F, S504F, S526F, S549F, S552F, S1501F, S1542F, S1566F, S1583F, S1584F, S1607F, S1635F, S1636F, S1652F, S1675F, S438F, S1359F, S1527F, S1528F, S1585F, S1586F, S1588F, S1606F, S1613F, S1614F, S1628F, S1653F, S425F, S464F, S480F, S511F, S787F, S1486F, S1543F, S1544F, S1565F, S1611F, S1612F, S1627F, S1629F, S1650F, S1651F, S1677F, S375F, S424F, S503F, S505F, S510F, S513F, S527F, S548F, S573F, S786F	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055333	17	41222967	17	43070950	55333	70000	rs80357390	NC_000017.11:43070949:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4956G>A (p.Met1652Ile)	BRCA1	M1652I, M548I, M1673I, M1605I, M1523I, M1582I, M1604I, M1611I, M1633I, M1649I, M459I, M460I, M467I, M477I, M502I, M504I, M510I, M546I, M1356I, M1563I, M1564I, M1580I, M1585I, M1483I, M1524I, M1525I, M1608I, M1632I, M1647I, M1672I, M372I, M421I, M461I, M482I, M500I, M507I, M524I, M545I, M549I, M1355I, M1498I, M1539I, M1540I, M1581I, M1583I, M1603I, M1624I, M1648I, M1650I, M1651I, M1674I, M439I, M440I, M481I, M501I, M506I, M522I, M547I, M570I, M783I, M1541I, M1562I, M1609I, M1610I, M1626I, M381I, M422I, M435I, M436I, M469I, M478I, M479I, M508I, M509I, M523I, M571I, M784I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041830	17	41222975	17	43070958	41830	50269	rs1799967	NC_000017.11:43070957:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4955T>C (p.Met1652Thr)	BRCA1	M1652T, M1673T, M1605T, M548T, M1539T, M1583T, M1585T, M1603T, M1625T, M1626T, M1647T, M1650T, M1651T, M381T, M421T, M459T, M461T, M469T, M478T, M504T, M506T, M508T, M545T, M549T, M571T, M1356T, M1563T, M1611T, M1624T, M1632T, M1633T, M1649T, M439T, M440T, M467T, M501T, M510T, M522T, M523T, M1483T, M1498T, M1524T, M1525T, M1541T, M1562T, M1564T, M1580T, M1582T, M1608T, M1609T, M1674T, M422T, M435T, M436T, M460T, M477T, M481T, M500T, M502T, M509T, M783T, M1355T, M1523T, M1540T, M1581T, M1604T, M1610T, M1648T, M1672T, M372T, M479T, M482T, M507T, M524T, M546T, M547T, M570T, M784T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037615	17	41222976	17	43070959	37615	46171	rs80356968	NC_000017.11:43070958:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4941C>G (p.Asn1647Lys)	BRCA1	N1600K, N1647K, N543K, N1668K, N1493K, N1557K, N1558K, N1577K, N1578K, N1580K, N1603K, N1606K, N1619K, N1620K, N1628K, N1644K, N435K, N497K, N503K, N504K, N505K, N542K, N566K, N779K, N1350K, N1520K, N1535K, N1559K, N1621K, N1642K, N1645K, N1669K, N416K, N430K, N455K, N456K, N462K, N474K, N477K, N495K, N496K, N501K, N517K, N540K, N544K, N565K, N1518K, N1519K, N1534K, N1536K, N1575K, N1604K, N1605K, N1627K, N1667K, N367K, N434K, N472K, N499K, N502K, N519K, N1351K, N1478K, N1576K, N1598K, N1599K, N1643K, N1646K, N376K, N417K, N431K, N454K, N464K, N473K, N476K, N518K, N541K, N778K	Hereditary cancer-predisposing syndrome	VCV000865710	17	41222990	17	43070973	865710	854304	rs80357302	NC_000017.11:43070972:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Dec 24, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4913A>T (p.Glu1638Val)	BRCA1	E1591V, E1638V, E1659V, E534V, E1526V, E1527V, E1549V, E1589V, E1595V, E1637V, E1658V, E1660V, E358V, E425V, E467V, E487V, E488V, E494V, E496V, E535V, E1341V, E1469V, E1484V, E1548V, E1550V, E1566V, E1569V, E1571V, E1634V, E407V, E447V, E463V, E492V, E508V, E532V, E557V, E1342V, E1509V, E1510V, E1511V, E1525V, E1567V, E1610V, E1611V, E1612V, E1619V, E1635V, E367V, E426V, E455V, E464V, E468V, E486V, E493V, E510V, E556V, E769V, E1568V, E1590V, E1594V, E1596V, E1597V, E1618V, E1633V, E1636V, E408V, E421V, E422V, E445V, E446V, E453V, E465V, E490V, E495V, E509V, E531V, E533V, E770V	not specified	VCV000868843	17	41223018	17	43071001	868843	854370	rs2052380495	NC_000017.11:43071000:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Mar 4, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4910C>T (p.Pro1637Leu)	BRCA1	P1637L, P1590L, P533L, P1658L, P1526L, P1547L, P1570L, P1595L, P1596L, P1632L, P1659L, P421L, P452L, P486L, P489L, P493L, P494L, P508L, P556L, P1341L, P1510L, P1524L, P1549L, P1566L, P1568L, P1609L, P1617L, P1636L, P366L, P406L, P425L, P463L, P464L, P466L, P485L, P495L, P507L, P1468L, P1525L, P1548L, P1567L, P1588L, P1593L, P1610L, P1634L, P1635L, P357L, P446L, P487L, P492L, P531L, P1340L, P1483L, P1508L, P1509L, P1565L, P1589L, P1594L, P1611L, P1618L, P1633L, P1657L, P407L, P420L, P424L, P444L, P445L, P454L, P462L, P467L, P491L, P532L, P534L, P509L, P530L, P555L, P768L, P769L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055314	17	41223021	17	43071004	55314	69981	rs80357048	NC_000017.11:43071003:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4883T>C (p.Met1628Thr)	BRCA1	M1628T, M1649T, M524T, M1581T, M485T, M498T, M1501T, M1539T, M1558T, M1584T, M1600T, M1601T, M1602T, M1623T, M1648T, M397T, M411T, M435T, M458T, M476T, M477T, M1332T, M1517T, M1538T, M1540T, M1557T, M1561T, M1608T, M1609T, M348T, M357T, M412T, M416T, M437T, M453T, M454T, M455T, M478T, M482T, M499T, M523T, M525T, M760T, M1459T, M1474T, M1515T, M1579T, M1585T, M1586T, M1625T, M415T, M436T, M443T, M445T, M483T, M484T, M486T, M500T, M521T, M547T, M1331T, M1499T, M1500T, M1516T, M1556T, M1559T, M1580T, M1587T, M1624T, M1626T, M1627T, M1650T, M398T, M457T, M480T, M522T, M546T, M759T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041828	17	41223048	17	43071031	41828	50267	rs4986854	NC_000017.11:43071030:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4868C>G (p.Ala1623Gly)	BRCA1	A1623G, A519G, A1576G, A1644G, A1512G, A1534G, A1535G, A1556G, A1580G, A1582G, A1597G, A1603G, A1643G, A392G, A411G, A432G, A475G, A494G, A495G, A517G, A520G, A755G, A1496G, A1510G, A1511G, A1575G, A1579G, A1581G, A406G, A410G, A431G, A438G, A448G, A471G, A472G, A479G, A493G, A1326G, A1327G, A1469G, A1533G, A1552G, A1595G, A1596G, A1619G, A1621G, A343G, A352G, A393G, A449G, A450G, A453G, A477G, A478G, A480G, A481G, A516G, A518G, A542G, A1494G, A1495G, A1551G, A1553G, A1554G, A1574G, A1604G, A1618G, A1620G, A1622G, A1645G, A407G, A430G, A440G, A452G, A473G, A541G, A754G, A1454G	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037614	17	41223063	17	43071046	37614	46170	rs80356862	NC_000017.11:43071045:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4840C>T (p.Pro1614Ser)	BRCA1	P1614S, P1635S, P1567S, P510S, P1318S, P1460S, P1524S, P1526S, P1543S, P1544S, P1573S, P1609S, P1612S, P1613S, P1636S, P401S, P421S, P423S, P470S, P472S, P508S, P1501S, P1525S, P1542S, P1547S, P1565S, P1571S, P1572S, P1587S, P1588S, P1595S, P1610S, P343S, P429S, P471S, P484S, P486S, P509S, P511S, P746S, P1485S, P1486S, P1503S, P1586S, P1594S, P1634S, P383S, P384S, P397S, P422S, P431S, P439S, P441S, P443S, P464S, P469S, P485S, P507S, P532S, P533S, P745S, P1317S, P1445S, P1487S, P1502S, P1545S, P1566S, P1570S, P1611S, P334S, P398S, P402S, P440S, P444S, P462S, P463S, P466S, P468S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055301	17	41223091	17	43071074	55301	69968	rs70953660	NC_000017.11:43071073:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4837A>G (p.Ser1613Gly)	BRCA1	S1613G, S1634G, S509G, S1566G, S1486G, S1524G, S1542G, S1543G, S1544G, S1633G, S382G, S383G, S397G, S421G, S428G, S442G, S461G, S468G, S744G, S1317G, S1541G, S1565G, S1572G, S1585G, S1593G, S1610G, S1612G, S422G, S430G, S439G, S462G, S463G, S469G, S471G, S483G, S507G, S532G, S1459G, S1500G, S1501G, S1502G, S1525G, S1546G, S1569G, S1571G, S1586G, S1587G, S1609G, S1635G, S333G, S342G, S400G, S438G, S465G, S484G, S485G, S506G, S510G, S1316G, S1444G, S1484G, S1485G, S1523G, S1564G, S1570G, S1594G, S1608G, S1611G, S396G, S401G, S420G, S440G, S443G, S467G, S470G, S508G, S531G, S745G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041827	17	41223094	17	43071077	41827	50266	rs1799966	NC_000017.11:43071076:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4837A>T (p.Ser1613Cys)	BRCA1	S1613C, S1634C, S509C, S1566C, S1486C, S1502C, S1524C, S1541C, S1544C, S1569C, S1570C, S1608C, S1611C, S1633C, S1635C, S401C, S443C, S471C, S483C, S484C, S1459C, S1484C, S1485C, S1543C, S1572C, S1586C, S342C, S382C, S396C, S420C, S421C, S422C, S430C, S438C, S440C, S463C, S467C, S745C, S1316C, S1501C, S1525C, S1565C, S1571C, S1594C, S1612C, S333C, S397C, S400C, S428C, S439C, S465C, S468C, S485C, S508C, S510C, S531C, S532C, S744C, S1317C, S1444C, S1500C, S1523C, S1542C, S1546C, S1564C, S1585C, S1587C, S1593C, S1609C, S1610C, S383C, S442C, S461C, S462C, S469C, S470C, S506C, S507C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000037613	17	41223094	17	43071077	37613	46169	rs1799966	NC_000017.11:43071076:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4816A>G (p.Lys1606Glu)	BRCA1	K1606E, K502E, K1627E, K1559E, K1452E, K1493E, K1495E, K1516E, K1534E, K1557E, K1563E, K1586E, K1601E, K1602E, K1603E, K1605E, K390E, K421E, K436E, K454E, K477E, K524E, K525E, K737E, K1310E, K1437E, K1477E, K1478E, K1518E, K1539E, K1579E, K1587E, K1628E, K376E, K389E, K393E, K460E, K463E, K464E, K499E, K500E, K1309E, K1479E, K1494E, K1535E, K1536E, K1537E, K1564E, K1578E, K326E, K375E, K413E, K415E, K431E, K433E, K455E, K456E, K462E, K478E, K738E, K1517E, K1558E, K1562E, K1565E, K1580E, K1604E, K1626E, K335E, K394E, K414E, K423E, K432E, K435E, K458E, K461E, K476E, K501E, K503E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037612	17	41223115	17	43071098	37612	46168	rs80356943	NC_000017.11:43071097:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4729T>C (p.Ser1577Pro)	BRCA1	S1577P, S473P, S1530P, S1598P, S1408P, S1466P, S1505P, S1529P, S1535P, S1549P, S1557P, S1558P, S1575P, S1576P, S347P, S360P, S365P, S406P, S407P, S425P, S447P, S1280P, S1487P, S1528P, S1534P, S1574P, S1597P, S361P, S392P, S403P, S426P, S429P, S435P, S449P, S495P, S1423P, S1450P, S1465P, S1488P, S1508P, S1510P, S1533P, S1536P, S1550P, S1572P, S1573P, S346P, S394P, S402P, S427P, S431P, S432P, S434P, S448P, S471P, S472P, S496P, S1281P, S1448P, S1449P, S1464P, S1489P, S1506P, S1507P, S1551P, S1599P, S297P, S306P, S364P, S384P, S385P, S386P, S404P, S433P, S470P, S474P, S708P, S709P	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055272	17	41223202	17	43071185	55272	69939	rs80356909	NC_000017.11:43071184:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4691T>C (p.Leu1564Pro)	BRCA1	L1564P, L1585P, L1517P, L460P, L1435P, L1453P, L1492P, L1493P, L1494P, L1497P, L1516P, L1521P, L1560P, L1562P, L1586P, L347P, L351P, L391P, L393P, L412P, L482P, L1410P, L1436P, L1437P, L1452P, L1474P, L1476P, L1515P, L1520P, L1538P, L1544P, L1545P, L1561P, L1584P, L333P, L348P, L373P, L381P, L394P, L420P, L422P, L436P, L461P, L695P, L1267P, L1268P, L1495P, L1536P, L1537P, L284P, L352P, L371P, L379P, L390P, L416P, L418P, L421P, L457P, L458P, L483P, L696P, L1395P, L1451P, L1475P, L1522P, L1523P, L1559P, L1563P, L293P, L334P, L372P, L389P, L413P, L414P, L419P, L434P, L435P, L459P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055262	17	41223240	17	43071223	55262	69929	rs56119278	NC_000017.11:43071222:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4682C>T (p.Thr1561Ile)	BRCA1	T1561I, T1582I, T457I, T1514I, T411I, T419I, T433I, T455I, T1265I, T1392I, T1407I, T1448I, T1449I, T1450I, T1471I, T1473I, T1494I, T1517I, T1533I, T331I, T368I, T387I, T391I, T413I, T416I, T417I, T432I, T480I, T692I, T1433I, T1489I, T1490I, T1513I, T1520I, T1535I, T1542I, T1558I, T344I, T370I, T376I, T388I, T1434I, T1472I, T1491I, T1492I, T1512I, T1534I, T1541I, T1556I, T1559I, T290I, T345I, T349I, T378I, T386I, T409I, T410I, T415I, T1264I, T1432I, T1518I, T1519I, T1557I, T1560I, T1581I, T1583I, T281I, T330I, T348I, T369I, T390I, T418I, T431I, T454I, T456I, T458I, T479I, T693I	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|BRCA1-related cancer predisposition|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000055259	17	41223249	17	43071232	55259	69926	rs56158747	NC_000017.11:43071231:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4675G>C (p.Glu1559Gln)	BRCA1	E1559Q, E455Q, E1580Q, E1512Q, E1447Q, E1516Q, E1554Q, E1556Q, E346Q, E384Q, E388Q, E407Q, E409Q, E413Q, E415Q, E417Q, E453Q, E477Q, E1262Q, E1263Q, E1390Q, E1469Q, E1487Q, E1510Q, E1517Q, E1518Q, E1540Q, E1581Q, E366Q, E367Q, E385Q, E411Q, E454Q, E478Q, E1430Q, E1446Q, E1488Q, E1489Q, E1490Q, E1511Q, E1515Q, E1531Q, E1539Q, E1555Q, E1557Q, E1579Q, E288Q, E342Q, E343Q, E376Q, E386Q, E408Q, E414Q, E416Q, E429Q, E452Q, E456Q, E690Q, E1431Q, E1432Q, E1448Q, E1470Q, E1471Q, E1492Q, E1532Q, E1533Q, E1558Q, E328Q, E329Q, E347Q, E368Q, E374Q, E389Q, E430Q, E431Q, E691Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000037605	17	41226348	17	43074331	37605	46161	rs80356988	NC_000017.11:43074330:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4675G>A (p.Glu1559Lys)	BRCA1	E1559K, E1580K, E1512K, E455K, E1431K, E1515K, E1517K, E1532K, E1539K, E1540K, E386K, E388K, E407K, E409K, E691K, E1262K, E1432K, E1446K, E1447K, E1469K, E1489K, E1490K, E1492K, E1510K, E1518K, E1533K, E288K, E347K, E366K, E368K, E384K, E385K, E415K, E430K, E452K, E478K, E690K, E1263K, E1487K, E1488K, E1516K, E1531K, E1555K, E1556K, E1557K, E1558K, E329K, E342K, E343K, E374K, E376K, E389K, E411K, E414K, E417K, E454K, E1390K, E1430K, E1448K, E1470K, E1471K, E1511K, E1554K, E1579K, E1581K, E328K, E346K, E367K, E408K, E413K, E416K, E429K, E431K, E453K, E456K, E477K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037604	17	41226348	17	43074331	37604	46160	rs80356988	NC_000017.11:43074330:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4636G>T (p.Asp1546Tyr)	BRCA1	D1546Y, D1567Y, D442Y, D1499Y, D1249Y, D1377Y, D1435Y, D1458Y, D1503Y, D1520Y, D1541Y, D1543Y, D1545Y, D1568Y, D333Y, D355Y, D376Y, D401Y, D418Y, D441Y, D465Y, D678Y, D1418Y, D1474Y, D1476Y, D1479Y, D1519Y, D1527Y, D1566Y, D275Y, D316Y, D330Y, D353Y, D354Y, D371Y, D372Y, D395Y, D396Y, D402Y, D404Y, D440Y, D1250Y, D1417Y, D1434Y, D1475Y, D1477Y, D1498Y, D1502Y, D1504Y, D1518Y, D1526Y, D1542Y, D1544Y, D361Y, D363Y, D373Y, D375Y, D394Y, D403Y, D417Y, D443Y, D1419Y, D1433Y, D1456Y, D1457Y, D1497Y, D1505Y, D315Y, D329Y, D334Y, D398Y, D400Y, D416Y, D439Y, D464Y, D677Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055246	17	41226387	17	43074370	55246	69913	rs28897691	NC_000017.11:43074369:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4636G>A (p.Asp1546Asn)	BRCA1	D1546N, D1567N, D442N, D1499N, D1250N, D1417N, D1433N, D1498N, D1520N, D1542N, D1545N, D1566N, D1568N, D329N, D353N, D363N, D403N, D417N, D678N, D1457N, D1474N, D1502N, D1504N, D1526N, D1527N, D1541N, D315N, D334N, D361N, D372N, D394N, D396N, D401N, D439N, D464N, D1418N, D1435N, D1475N, D1476N, D1479N, D1518N, D1544N, D316N, D330N, D333N, D355N, D371N, D375N, D404N, D418N, D465N, D1249N, D1377N, D1419N, D1434N, D1456N, D1458N, D1477N, D1497N, D1503N, D1505N, D1519N, D1543N, D275N, D354N, D373N, D376N, D395N, D398N, D400N, D402N, D416N, D440N, D441N, D443N, D677N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055245	17	41226387	17	43074370	55245	69912	rs28897691	NC_000017.11:43074369:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4600G>A (p.Val1534Met)	BRCA1	V1534M, V1555M, V430M, V1487M, V1407M, V1421M, V1422M, V1486M, V1491M, V1506M, V1514M, V1530M, V1554M, V1556M, V383M, V392M, V1444M, V1445M, V1446M, V1464M, V1485M, V1493M, V1508M, V1515M, V1529M, V1531M, V263M, V303M, V321M, V341M, V359M, V361M, V363M, V382M, V388M, V389M, V391M, V428M, V429M, V666M, V1365M, V1406M, V1423M, V1462M, V1465M, V1467M, V1490M, V1532M, V317M, V349M, V351M, V360M, V364M, V384M, V390M, V406M, V427M, V431M, V452M, V665M, V1237M, V1463M, V1492M, V1507M, V1533M, V304M, V318M, V322M, V342M, V343M, V386M, V404M, V405M, V453M, V1238M, V1405M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055235	17	41226423	17	43074406	55235	69902	rs55815649	NC_000017.11:43074405:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4535G>T (p.Ser1512Ile)	BRCA1	S1512I, S408I, S1533I, S1465I, S1343I, S1385I, S1441I, S1442I, S1468I, S1492I, S1508I, S1509I, S1510I, S296I, S321I, S361I, S366I, S370I, S383I, S409I, S644I, S1215I, S1422I, S1423I, S1440I, S1445I, S1463I, S1464I, S1471I, S1493I, S1507I, S241I, S282I, S327I, S329I, S337I, S341I, S342I, S362I, S367I, S384I, S407I, S430I, S1383I, S1400I, S1401I, S1443I, S1469I, S1484I, S1485I, S1486I, S1511I, S1534I, S281I, S299I, S338I, S364I, S369I, S382I, S405I, S406I, S431I, S1216I, S1384I, S1399I, S1424I, S1470I, S1532I, S295I, S300I, S319I, S320I, S339I, S360I, S368I, S643I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041826	17	41226488	17	43074471	41826	50265	rs1800744	NC_000017.11:43074470:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4520G>C (p.Arg1507Thr)	BRCA1	R1507T, R1460T, R1528T, R403T, R1418T, R1437T, R1458T, R1459T, R1464T, R1465T, R1479T, R1487T, R1488T, R1504T, R1506T, R277T, R315T, R332T, R333T, R355T, R356T, R378T, R379T, R426T, R1210T, R1338T, R1379T, R1380T, R1395T, R1436T, R1466T, R1480T, R1503T, R1529T, R236T, R314T, R324T, R334T, R361T, R362T, R400T, R404T, R425T, R638T, R639T, R1378T, R1419T, R1438T, R1440T, R1463T, R1502T, R1505T, R1527T, R290T, R316T, R322T, R337T, R357T, R363T, R377T, R401T, R402T, R1211T, R1394T, R1396T, R1417T, R1435T, R1481T, R276T, R291T, R294T, R295T, R336T, R359T, R364T, R365T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041825	17	41226503	17	43074486	41825	50264	rs80357470	NC_000017.11:43074485:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4484G>C (p.Arg1495Thr)	BRCA1	R1495T, R391T, R1516T, R1448T, R1199T, R1326T, R1367T, R1423T, R1425T, R1426T, R1428T, R1446T, R1452T, R1453T, R1467T, R1475T, R1515T, R1517T, R265T, R303T, R304T, R312T, R321T, R325T, R347T, R349T, R365T, R414T, R627T, R1366T, R1368T, R1382T, R1468T, R1494T, R224T, R279T, R282T, R310T, R353T, R366T, R1383T, R1406T, R1447T, R1451T, R1469T, R1476T, R1490T, R1491T, R1493T, R264T, R278T, R302T, R320T, R322T, R324T, R345T, R352T, R388T, R390T, R392T, R413T, R626T, R389T, R1198T, R1384T, R1405T, R1407T, R1424T, R1454T, R1492T, R283T, R343T, R344T, R350T, R351T, R367T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000245697	17	41228505	17	43076488	245697	245029	rs80357389	NC_000017.11:43076487:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4484G>T (p.Arg1495Met)	BRCA1	R1495M, R1516M, R1448M, R391M, R1198M, R1326M, R1368M, R1383M, R1384M, R1469M, R1491M, R1493M, R283M, R303M, R310M, R320M, R321M, R324M, R352M, R365M, R366M, R389M, R626M, R1406M, R1407M, R1423M, R1424M, R1454M, R1476M, R1515M, R224M, R279M, R325M, R343M, R344M, R347M, R353M, R367M, R392M, R414M, R1199M, R1382M, R1405M, R1425M, R1428M, R1447M, R1453M, R1468M, R1490M, R1494M, R282M, R302M, R304M, R322M, R350M, R388M, R390M, R627M, R1366M, R1367M, R1426M, R1446M, R1451M, R1452M, R1467M, R1475M, R1492M, R1517M, R264M, R265M, R278M, R312M, R345M, R349M, R351M, R413M	Fanconi anemia, complementation group S|Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided|Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037598	17	41228505	17	43076488	37598	46154	rs80357389	NC_000017.11:43076487:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4484G>A (p.Arg1495Lys)	BRCA1	R1495K, R1448K, R391K, R1516K, R1198K, R1382K, R1453K, R1469K, R265K, R278K, R303K, R321K, R345K, R347K, R367K, R392K, R1199K, R1367K, R1383K, R1407K, R1423K, R1447K, R1454K, R1468K, R1476K, R1490K, R224K, R282K, R302K, R310K, R325K, R365K, R366K, R1326K, R1424K, R1426K, R1446K, R1452K, R1467K, R1493K, R1494K, R283K, R304K, R312K, R322K, R324K, R350K, R388K, R414K, R626K, R1366K, R1368K, R1384K, R1405K, R1406K, R1425K, R1428K, R1451K, R1475K, R1491K, R1492K, R1515K, R1517K, R264K, R279K, R320K, R343K, R344K, R349K, R351K, R352K, R353K, R389K, R390K, R413K, R627K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037597	17	41228505	17	43076488	37597	46153	rs80357389	NC_000017.11:43076487:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4402A>C (p.Asn1468His)	BRCA1	N1468H, N1421H, N1489H, N364H, N1299H, N1355H, N1357H, N1396H, N1398H, N1420H, N1425H, N1440H, N238H, N251H, N275H, N297H, N298H, N317H, N339H, N1339H, N1340H, N1378H, N1380H, N1397H, N1399H, N1401H, N1426H, N1427H, N1449H, N237H, N276H, N294H, N322H, N323H, N326H, N338H, N362H, N365H, N387H, N600H, N1171H, N1379H, N1419H, N1441H, N1448H, N1463H, N1467H, N1490H, N197H, N255H, N277H, N285H, N293H, N295H, N320H, N340H, N361H, N599H, N1172H, N1341H, N1356H, N1424H, N1442H, N1464H, N1465H, N1466H, N1488H, N252H, N256H, N283H, N316H, N318H, N324H, N325H, N363H, N386H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055193	17	41228587	17	43076570	55193	69860	rs80357022	NC_000017.11:43076569:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4327C>G (p.Arg1443Gly)	BRCA1	R1443G, R340G, R1396G, R1353G, R1372G, R1395G, R1415G, R1416G, R213G, R229G, R259G, R272G, R299G, R574G, R1315G, R1332G, R1373G, R1375G, R1394G, R1400G, R1402G, R1439G, R212G, R251G, R269G, R270G, R300G, R313G, R338G, R1316G, R1330G, R1331G, R1417G, R1442G, R227G, R252G, R293G, R314G, R339G, R575G, R1147G, R1274G, R1354G, R1355G, R1371G, R1376G, R1401G, R1441G, R172G, R230G, R231G, R260G, R273G, R291G, R292G, R295G, R298G, R301G, R337G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017676	17	41234451	17	43082434	17676	32715	rs41293455	NC_000017.11:43082433:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4255G>C (p.Glu1419Gln)	BRCA1	E1419Q, E316Q, E1372Q, E1329Q, E1347Q, E1378Q, E206Q, E228Q, E235Q, E267Q, E315Q, E550Q, E1123Q, E1291Q, E1306Q, E1308Q, E1348Q, E1349Q, E1377Q, E1391Q, E1392Q, E189Q, E205Q, E248Q, E249Q, E271Q, E276Q, E290Q, E313Q, E314Q, E1307Q, E1330Q, E1370Q, E1418Q, E148Q, E236Q, E245Q, E277Q, E551Q, E1250Q, E1292Q, E1331Q, E1351Q, E1352Q, E1371Q, E1376Q, E1393Q, E1415Q, E1417Q, E188Q, E203Q, E207Q, E227Q, E246Q, E268Q, E269Q, E274Q, E275Q, E289Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055154	17	41234523	17	43082506	55154	69821	rs80357309	NC_000017.11:43082505:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4204C>T (p.His1402Tyr)	BRCA1	H1402Y, H299Y, H1355Y, H1233Y, H1275Y, H1289Y, H1312Y, H1314Y, H1330Y, H1334Y, H1335Y, H257Y, H260Y, H298Y, H1291Y, H1331Y, H1353Y, H1361Y, H1374Y, H1376Y, H171Y, H186Y, H190Y, H210Y, H211Y, H218Y, H232Y, H250Y, H251Y, H297Y, H533Y, H1106Y, H1290Y, H1313Y, H131Y, H1375Y, H1398Y, H1400Y, H172Y, H189Y, H219Y, H228Y, H229Y, H252Y, H254Y, H259Y, H272Y, H1274Y, H1332Y, H1354Y, H1359Y, H1360Y, H1401Y, H188Y, H231Y, H258Y, H273Y, H296Y, H534Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055140	17	41234574	17	43082557	55140	69807	rs80357365	NC_000017.11:43082556:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4132G>A (p.Val1378Ile)	BRCA1	V1378I, V1331I, V275I, V1267I, V1307I, V1310I, V1330I, V1337I, V1351I, V194I, V230I, V236I, V249I, V107I, V1210I, V1250I, V1266I, V1311I, V147I, V164I, V166I, V187I, V205I, V207I, V227I, V233I, V235I, V510I, V1308I, V1336I, V1352I, V163I, V204I, V208I, V228I, V272I, V273I, V274I, V1082I, V1251I, V1289I, V1290I, V1375I, V1377I, V148I, V186I, V195I, V234I, V248I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055111	17	41243014	17	43090997	55111	69778	rs28897690	NC_000017.11:43090996:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4081A>T (p.Met1361Leu)	BRCA1|LOC126862571	M1361L, M1314L, M1233L, M1272L, M1290L, M1313L, M1273L, M1319L, M1335L, M1358L, M1065L, M1250L, M1291L, M1294L, M1334L, M1360L, M1193L, M1234L, M1249L, M1293L, M1320L, M493L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000812551	17	41243467	17	43091450	812551	800791	rs80357218	NC_000017.11:43091449:T:A	single nucleotide variant	intron variant|missense variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4081A>C (p.Met1361Leu)	BRCA1|LOC126862571	M1361L, M1314L, M1065L, M1233L, M1293L, M1335L, M1234L, M1249L, M1250L, M1273L, M1291L, M1358L, M1360L, M1290L, M1313L, M1334L, M1193L, M1272L, M1294L, M1319L, M1320L, M493L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055099	17	41243467	17	43091450	55099	69766	rs80357218	NC_000017.11:43091449:T:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4046C>T (p.Thr1349Met)	BRCA1|LOC126862571	T1349M, T1302M, T1237M, T1278M, T1301M, T1221M, T1261M, T1279M, T1282M, T1307M, T1322M, T481M, T1053M, T1260M, T1323M, T1348M, T1181M, T1222M, T1238M, T1281M, T1308M, T1346M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055085	17	41243502	17	43091485	55085	69752	rs80357345	NC_000017.11:43091484:G:A	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4039A>G (p.Arg1347Gly)	BRCA1|LOC126862571	R1347G, R1300G, R1321G, R1344G, R479G, R1179G, R1220G, R1258G, R1279G, R1299G, R1305G, R1320G, R1051G, R1235G, R1236G, R1259G, R1277G, R1306G, R1346G, R1219G, R1276G, R1280G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041821	17	41243509	17	43091492	41821	50260	rs28897689	NC_000017.11:43091491:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4036G>A (p.Glu1346Lys)	BRCA1|LOC126862571	E1346K, E1299K, E1050K, E1178K, E1275K, E1276K, E1218K, E1258K, E1305K, E1235K, E1279K, E1298K, E1304K, E1345K, E1219K, E1234K, E1257K, E1278K, E1319K, E1320K, E1343K, E478K	BRCA1-related cancer predisposition|Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|not provided	VCV000037561	17	41243512	17	43091495	37561	46117	rs80357407	NC_000017.11:43091494:C:T	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3958T>C (p.Ser1320Pro)	BRCA1|LOC126862571	S1320P, S1273P, S1192P, S1250P, S1278P, S1293P, S1294P, S1317P, S1209P, S1231P, S1252P, S1253P, S1279P, S452P, S1024P, S1152P, S1193P, S1208P, S1232P, S1249P, S1272P, S1319P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125659	17	41243590	17	43091573	125659	131197	rs80356855	NC_000017.11:43091572:A:G	single nucleotide variant	missense variant|intron variant	Benign	Jan 1, 2000	no assertion criteria provided							
NM_007294.4(BRCA1):c.3823A>G (p.Ile1275Val)	BRCA1|LOC126862571	I1275V, I1228V, I1107V, I1147V, I1205V, I1227V, I1233V, I407V, I1164V, I1187V, I1204V, I1208V, I1274V, I1148V, I1207V, I1234V, I1248V, I979V, I1163V, I1186V, I1249V, I1272V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037549	17	41243725	17	43091708	37549	46105	rs80357280	NC_000017.11:43091707:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.3797G>C (p.Ser1266Thr)	BRCA1|LOC126862571	S1266T, S1219T, S1138T, S1178T, S1195T, S1196T, S1224T, S1263T, S398T, S970T, S1139T, S1154T, S1155T, S1225T, S1239T, S1240T, S1098T, S1177T, S1198T, S1218T, S1199T, S1265T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055009	17	41243751	17	43091734	55009	69676	rs80357160	NC_000017.11:43091733:C:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3748G>A (p.Glu1250Lys)	BRCA1|LOC126862571	E1250K, E1203K, E1122K, E1182K, E1183K, E1208K, E1249K, E1138K, E1161K, E1162K, E382K, E1082K, E1123K, E1139K, E1179K, E1180K, E1209K, E1223K, E1247K, E1202K, E1224K, E954K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054987	17	41243800	17	43091783	54987	69654	rs28897686	NC_000017.11:43091782:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3739G>A (p.Val1247Ile)	LOC126862571|BRCA1	V1247I, V1200I, V1119I, V1136I, V1179I, V1220I, V1221I, V1158I, V1176I, V1177I, V1180I, V1206I, V1246I, V1079I, V1199I, V1205I, V379I, V1120I, V1135I, V1159I, V1244I, V951I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054985	17	41243809	17	43091792	54985	69652	rs80357191	NC_000017.11:43091791:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3724A>G (p.Thr1242Ala)	BRCA1|LOC126862571	T1242A, T1195A, T1172A, T1174A, T1194A, T1201A, T1215A, T946A, T1074A, T1115A, T1131A, T1171A, T1175A, T1216A, T374A, T1130A, T1153A, T1241A, T1114A, T1154A, T1200A, T1239A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054982	17	41243824	17	43091807	54982	69649	rs80357037	NC_000017.11:43091806:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.3713C>T (p.Pro1238Leu)	BRCA1|LOC126862571	P1238L, P1191L, P1070L, P1127L, P1196L, P942L, P1149L, P1171L, P1197L, P1211L, P370L, P1126L, P1150L, P1168L, P1190L, P1110L, P1111L, P1167L, P1170L, P1212L, P1235L, P1237L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037543	17	41243835	17	43091818	37543	46099	rs28897688	NC_000017.11:43091817:G:A	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3708T>G (p.Asn1236Lys)	BRCA1|LOC126862571	N1236K, N1189K, N1108K, N1109K, N1125K, N1148K, N1165K, N1209K, N1210K, N1068K, N1168K, N1188K, N1233K, N368K, N940K, N1147K, N1194K, N1195K, N1124K, N1166K, N1169K, N1235K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054970	17	41243840	17	43091823	54970	69637	rs28897687	NC_000017.11:43091822:A:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.3657G>T (p.Glu1219Asp)	BRCA1|LOC126862571	E1051D, E1107D, E1192D, E1219D, E351D, E1108D, E1148D, E1151D, E1152D, E1177D, E1178D, E1092D, E1130D, E1149D, E1171D, E1172D, E1193D, E1091D, E1131D, E1216D, E1218D, E923D	Hereditary breast ovarian cancer syndrome	VCV002035518	17	41243891	17	43091874	2035518	2097302		NC_000017.11:43091873:C:A	single nucleotide variant	missense variant|intron variant	Benign	Oct 14, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3657G>C (p.Glu1219Asp)	BRCA1|LOC126862571	E1219D, E1172D, E1051D, E1091D, E1092D, E1149D, E1171D, E1178D, E1216D, E351D, E1131D, E1177D, E1192D, E1218D, E1107D, E1151D, E1193D, E923D, E1108D, E1130D, E1148D, E1152D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037537	17	41243891	17	43091874	37537	46093	rs80356876	NC_000017.11:43091873:C:G	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.3640G>A (p.Glu1214Lys)	BRCA1|LOC126862571	E1214K, E1167K, E1125K, E1126K, E1146K, E1147K, E1173K, E1188K, E1211K, E1172K, E1187K, E918K, E1086K, E1087K, E1102K, E1103K, E1166K, E1213K, E1046K, E1143K, E1144K, E346K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054948	17	41243908	17	43091891	54948	69615	rs80356923	NC_000017.11:43091890:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3608G>A (p.Arg1203Gln)	BRCA1|LOC126862571	R1203Q, R1156Q, R1133Q, R1162Q, R1176Q, R1177Q, R1200Q, R1202Q, R907Q, R1035Q, R1132Q, R1135Q, R1136Q, R1075Q, R1076Q, R1092Q, R1115Q, R1155Q, R1161Q, R335Q, R1091Q, R1114Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054935	17	41243940	17	43091923	54935	69602	rs55930959	NC_000017.11:43091922:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3601G>A (p.Gly1201Ser)	BRCA1|LOC126862571	G1201S, G1154S, G1089S, G1090S, G1112S, G1131S, G1153S, G1175S, G1200S, G905S, G1073S, G1113S, G1134S, G1174S, G1198S, G1033S, G1074S, G1130S, G1133S, G1159S, G333S, G1160S	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000054932	17	41243947	17	43091930	54932	69599	rs55725337	NC_000017.11:43091929:C:T	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3600G>T (p.Gln1200His)	BRCA1|LOC126862571	Q1200H, Q1153H, Q1158H, Q1159H, Q1173H, Q1174H, Q1032H, Q1112H, Q1132H, Q1197H, Q1199H, Q1089H, Q1072H, Q1073H, Q1088H, Q1133H, Q332H, Q904H, Q1111H, Q1129H, Q1130H, Q1152H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054931	17	41243948	17	43091931	54931	69598	rs56214134	NC_000017.11:43091930:C:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.3600G>C (p.Gln1200His)	BRCA1|LOC126862571	Q1200H, Q1153H, Q1072H, Q1112H, Q1129H, Q1130H, Q1133H, Q1174H, Q1199H, Q1073H, Q1088H, Q1152H, Q1158H, Q1159H, Q1173H, Q1197H, Q332H, Q1032H, Q1089H, Q1111H, Q1132H, Q904H	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Familial cancer of breast|BRCA1-related cancer predisposition|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054930	17	41243948	17	43091931	54930	69597	rs56214134	NC_000017.11:43091930:C:G	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3548A>G (p.Lys1183Arg)	BRCA1|LOC126862571	K1183R, K1136R, K1056R, K1113R, K1115R, K1182R, K1055R, K1141R, K1015R, K1072R, K1094R, K1095R, K1116R, K1157R, K315R, K887R, K1071R, K1112R, K1135R, K1142R, K1156R, K1180R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041818	17	41244000	17	43091983	41818	50257	rs16942	NC_000017.11:43091982:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3541G>A (p.Val1181Ile)	BRCA1|LOC126862571	V1181I, V1134I, V1053I, V1093I, V1110I, V1111I, V1133I, V1178I, V1013I, V1069I, V1092I, V1154I, V1054I, V1070I, V1113I, V1139I, V1155I, V1180I, V885I, V313I, V1114I, V1140I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054911	17	41244007	17	43091990	54911	69578	rs56336919	NC_000017.11:43091989:C:T	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.3463G>C (p.Asp1155His)	BRCA1|LOC126862571	D1155H, D1108H, D1066H, D1128H, D1152H, D987H, D1027H, D1043H, D1085H, D1114H, D1129H, D859H, D1113H, D1028H, D1044H, D1067H, D1084H, D1087H, D1088H, D1107H, D1154H, D287H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054891	17	41244085	17	43092068	54891	69558	rs80357484	NC_000017.11:43092067:C:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3448C>T (p.Pro1150Ser)	BRCA1|LOC126862571	P1150S, P1103S, P1022S, P1039S, P282S, P1023S, P1038S, P1062S, P1082S, P1109S, P1147S, P1061S, P1102S, P1108S, P1124S, P1079S, P1080S, P1083S, P1123S, P1149S, P854S, P982S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054887	17	41244100	17	43092083	54887	69554	rs80357272	NC_000017.11:43092082:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.3418A>G (p.Ser1140Gly)	BRCA1|LOC126862571	S1140G, S1093G, S1029G, S1051G, S1069G, S1092G, S1114G, S972G, S1013G, S1028G, S1072G, S1099G, S844G, S1012G, S1070G, S1098G, S1113G, S1139G, S272G, S1052G, S1073G, S1137G	BRCA1-related cancer predisposition	VCV000041817	17	41244130	17	43092113	41817	50256	rs2227945	NC_000017.11:43092112:T:C	single nucleotide variant	intron variant|missense variant	Benign	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.3416G>T (p.Ser1139Ile)	BRCA1|LOC126862571	S1139I, S1092I, S1051I, S1072I, S1091I, S1011I, S1012I, S1027I, S1112I, S1136I, S843I, S971I, S1028I, S1050I, S1097I, S1138I, S271I, S1068I, S1069I, S1071I, S1098I, S1113I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054873	17	41244132	17	43092115	54873	69540	rs80357228	NC_000017.11:43092114:C:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.3327A>C (p.Lys1109Asn)	BRCA1|LOC126862571	K1109N, K1062N, K1061N, K1067N, K1108N, K1039N, K1042N, K1021N, K1068N, K1083N, K813N, K981N, K1020N, K1038N, K1041N, K1082N, K1106N, K941N, K982N, K997N, K998N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037522	17	41244221	17	43092204	37522	46078	rs41293449	NC_000017.11:43092203:T:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3302G>A (p.Ser1101Asn)	BRCA1|LOC126862571	S1101N, S1054N, S1013N, S1030N, S1034N, S1060N, S1100N, S973N, S989N, S933N, S1059N, S1074N, S1075N, S1098N, S1012N, S1031N, S1033N, S1053N, S805N, S974N, S990N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054830	17	41244246	17	43092229	54830	69497	rs41293447	NC_000017.11:43092228:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3296C>T (p.Pro1099Leu)	BRCA1|LOC126862571	P1099L, P1052L, P1031L, P1058L, P1098L, P972L, P1010L, P1011L, P1051L, P1057L, P1096L, P971L, P987L, P1028L, P1029L, P1032L, P1072L, P803L, P931L, P1073L, P988L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041816	17	41244252	17	43092235	41816	50255	rs80357201	NC_000017.11:43092234:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3143G>T (p.Gly1048Val)	BRCA1	G1048V, G1001V, G1007V, G1022V, G1045V, G1047V, G960V, G980V, G1000V, G936V, G937V, G978V, G880V, G1006V, G1021V, G752V, G920V, G921V, G959V, G977V, G981V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054777	17	41244405	17	43092388	54777	69444	rs80356899	NC_000017.11:43092387:C:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.3130A>G (p.Ile1044Val)	BRCA1	I1044V, I997V, I1017V, I1018V, I1041V, I917V, I932V, I973V, I974V, I1002V, I1003V, I955V, I976V, I876V, I916V, I933V, I956V, I1043V, I748V, I977V, I996V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037510	17	41244418	17	43092401	37510	46066	rs80357271	NC_000017.11:43092400:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3119G>A (p.Ser1040Asn)	BRCA1	S1040N, S993N, S1014N, S1039N, S992N, S998N, S872N, S913N, S929N, S969N, S1013N, S928N, S972N, S973N, S1037N, S744N, S912N, S951N, S952N, S970N, S999N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017670	17	41244429	17	43092412	17670	32709	rs4986852	NC_000017.11:43092411:C:T	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3113A>G (p.Glu1038Gly)	BRCA1	E1038G, E991G, E1012G, E742G, E870G, E927G, E971G, E996G, E949G, E911G, E926G, E950G, E967G, E970G, E990G, E1011G, E1035G, E1037G, E910G, E968G, E997G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041815	17	41244435	17	43092418	41815	50254	rs16941	NC_000017.11:43092417:T:C	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3083G>A (p.Arg1028His)	BRCA1	R1028H, R981H, R1001H, R916H, R940H, R957H, R980H, R986H, R860H, R901H, R917H, R1027H, R900H, R960H, R961H, R1002H, R1025H, R732H, R939H, R958H, R987H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037507	17	41244465	17	43092448	37507	46063	rs80357459	NC_000017.11:43092447:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3082C>T (p.Arg1028Cys)	BRCA1	R1028C, R981C, R1002C, R901C, R940C, R957C, R980C, R987C, R1025C, R958C, R732C, R860C, R900C, R916C, R917C, R939C, R961C, R986C, R1001C, R1027C, R960C	BRCA1-related cancer predisposition	VCV000037506	17	41244466	17	43092449	37506	46062	rs80357049	NC_000017.11:43092448:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.3024G>A (p.Met1008Ile)	BRCA1	M1008I, M961I, M881I, M938I, M940I, M960I, M982I, M712I, M840I, M897I, M941I, M981I, M1005I, M880I, M919I, M920I, M937I, M966I, M967I, M1007I, M896I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041814	17	41244524	17	43092507	41814	50253	rs1800704	NC_000017.11:43092506:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3022A>G (p.Met1008Val)	BRCA1	M1008V, M961V, M897V, M966V, M967V, M1005V, M712V, M937V, M938V, M982V, M840V, M896V, M941V, M981V, M1007V, M880V, M881V, M919V, M920V, M940V, M960V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054755	17	41244526	17	43092509	54755	69422	rs56321129	NC_000017.11:43092508:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2912A>G (p.His971Arg)	BRCA1	H971R, H924R, H803R, H883R, H901R, H903R, H675R, H844R, H882R, H904R, H929R, H970R, H843R, H860R, H923R, H968R, H859R, H900R, H930R, H944R, H945R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000628452	17	41244636	17	43092619	628452	618626	rs1567793641	NC_000017.11:43092618:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.2884G>A (p.Glu962Lys)	BRCA1	E962K, E915K, E834K, E835K, E851K, E873K, E794K, E920K, E921K, E935K, E666K, E850K, E891K, E894K, E936K, E874K, E892K, E895K, E914K, E959K, E961K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054709	17	41244664	17	43092647	54709	69376	rs80356955	NC_000017.11:43092646:C:T	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.2798G>C (p.Gly933Ala)	BRCA1	G933A, G886A, G821A, G885A, G907A, G637A, G805A, G844A, G845A, G865A, G866A, G930A, G765A, G822A, G863A, G891A, G906A, G932A, G806A, G862A, G892A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000233288	17	41244750	17	43092733	233288	236054	rs80356941	NC_000017.11:43092732:C:G	single nucleotide variant	intron variant|missense variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.2773A>C (p.Ile925Leu)	BRCA1	I925L, I878L, I629L, I798L, I837L, I883L, I898L, I922L, I813L, I836L, I854L, I797L, I814L, I857L, I899L, I757L, I855L, I858L, I877L, I884L, I924L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037489	17	41244775	17	43092758	37489	46045	rs4986847	NC_000017.11:43092757:T:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2758G>A (p.Val920Ile)	BRCA1	V920I, V873I, V808I, V852I, V872I, V624I, V793I, V850I, V809I, V831I, V849I, V878I, V917I, V853I, V893I, V894I, V919I, V752I, V792I, V832I, V879I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037488	17	41244790	17	43092773	37488	46044	rs80357361	NC_000017.11:43092772:C:T	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.2669G>T (p.Gly890Val)	BRCA1	G890V, G843V, G594V, G762V, G820V, G823V, G849V, G887V, G889V, G722V, G779V, G802V, G819V, G822V, G863V, G763V, G778V, G801V, G842V, G848V, G864V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037479	17	41244879	17	43092862	37479	46035	rs80356874	NC_000017.11:43092861:C:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2612C>T (p.Pro871Leu)	BRCA1	P871L, P824L, P703L, P743L, P801L, P803L, P845L, P744L, P782L, P783L, P800L, P868L, P804L, P829L, P830L, P844L, P575L, P759L, P760L, P823L, P870L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041812	17	41244936	17	43092919	41812	50251	rs799917	NC_000017.11:43092918:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2597G>A (p.Arg866His)	BRCA1	R866H, R819H, R738H, R755H, R795H, R824H, R839H, R863H, R799H, R570H, R739H, R754H, R777H, R818H, R825H, R840H, R865H, R698H, R778H, R796H, R798H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054613	17	41244951	17	43092934	54613	69280	rs80356911	NC_000017.11:43092933:C:T	single nucleotide variant	intron variant|missense variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.2596C>T (p.Arg866Cys)	BRCA1	R866C, R819C, R738C, R754C, R755C, R778C, R798C, R799C, R865C, R570C, R777C, R796C, R825C, R698C, R795C, R824C, R839C, R739C, R818C, R840C, R863C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041811	17	41244952	17	43092935	41811	50250	rs41286300	NC_000017.11:43092934:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2584A>G (p.Lys862Glu)	BRCA1	K862E, K815E, K773E, K792E, K794E, K566E, K735E, K795E, K820E, K861E, K694E, K734E, K750E, K751E, K774E, K791E, K836E, K859E, K814E, K821E, K835E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037476	17	41244964	17	43092947	37476	46032	rs80356927	NC_000017.11:43092946:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2566T>C (p.Tyr856His)	BRCA1	Y856H, Y809H, Y786H, Y808H, Y728H, Y768H, Y814H, Y815H, Y829H, Y767H, Y830H, Y853H, Y560H, Y688H, Y729H, Y744H, Y745H, Y785H, Y788H, Y789H, Y855H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054604	17	41244982	17	43092965	54604	69271	rs80356892	NC_000017.11:43092964:A:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2525A>G (p.Glu842Gly)	BRCA1	E842G, E795G, E731G, E753G, E841G, E771G, E774G, E775G, E801G, E839G, E546G, E674G, E754G, E794G, E800G, E815G, E714G, E715G, E730G, E772G, E816G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091592	17	41245023	17	43093006	91592	97069	rs28897684	NC_000017.11:43093005:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2522G>A (p.Arg841Gln)	BRCA1	R841Q, R794Q, R714Q, R729Q, R773Q, R799Q, R800Q, R673Q, R753Q, R793Q, R815Q, R545Q, R713Q, R730Q, R770Q, R771Q, R752Q, R774Q, R814Q, R838Q, R840Q	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054591	17	41245026	17	43093009	54591	69258	rs80357337	NC_000017.11:43093008:C:T	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2521C>T (p.Arg841Trp)	BRCA1	R841W, R794W, R840W, R673W, R730W, R752W, R799W, R838W, R545W, R713W, R770W, R773W, R814W, R815W, R729W, R753W, R771W, R800W, R714W, R774W, R793W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017681	17	41245027	17	43093010	17681	32720	rs1800709	NC_000017.11:43093009:G:A	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2515C>T (p.His839Tyr)	BRCA1	H543Y, H671Y, H711Y, H712Y, H727Y, H728Y, H750Y, H751Y, H768Y, H769Y, H771Y, H772Y, H791Y, H792Y, H797Y, H798Y, H812Y, H813Y, H836Y, H838Y, H839Y	Ovarian cancer	VCV002445306	17	41245033	17	43093016	2445306	2419032		NC_000017.11:43093015:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jan 1, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2477C>A (p.Thr826Lys)	BRCA1	T826K, T779K, T738K, T755K, T784K, T800K, T530K, T715K, T737K, T759K, T658K, T698K, T758K, T778K, T799K, T825K, T699K, T714K, T756K, T785K, T823K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037473	17	41245071	17	43093054	37473	46029	rs28897683	NC_000017.11:43093053:G:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2458A>G (p.Lys820Glu)	BRCA1	K820E, K773E, K524E, K753E, K779E, K817E, K693E, K708E, K732E, K750E, K794E, K652E, K709E, K731E, K749E, K772E, K778E, K793E, K692E, K752E, K819E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041810	17	41245090	17	43093073	41810	50249	rs56082113	NC_000017.11:43093072:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2428A>T (p.Asn810Tyr)	BRCA1	N810Y, N763Y, N642Y, N721Y, N722Y, N768Y, N769Y, N809Y, N699Y, N742Y, N762Y, N783Y, N784Y, N698Y, N514Y, N682Y, N683Y, N739Y, N740Y, N743Y, N807Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054567	17	41245120	17	43093103	54567	69234	rs28897682	NC_000017.11:43093102:T:A	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2412G>C (p.Gln804His)	BRCA1	Q804H, Q757H, Q676H, Q693H, Q734H, Q778H, Q777H, Q803H, Q508H, Q636H, Q715H, Q756H, Q801H, Q677H, Q692H, Q716H, Q733H, Q736H, Q737H, Q762H, Q763H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054561	17	41245136	17	43093119	54561	69228	rs55746541	NC_000017.11:43093118:C:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2351C>T (p.Ser784Leu)	BRCA1	S784L, S737L, S656L, S673L, S695L, S713L, S714L, S736L, S742L, S757L, S758L, S616L, S657L, S743L, S783L, S488L, S696L, S716L, S717L, S672L, S781L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037464	17	41245197	17	43093180	37464	46020	rs55914168	NC_000017.11:43093179:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.2335A>T (p.Thr779Ser)	BRCA1	T732S, T779S, T776S, T483S, T652S, T667S, T691S, T731S, T738S, T778S, T711S, T752S, T611S, T651S, T668S, T690S, T708S, T709S, T712S, T737S, T753S	Hereditary breast ovarian cancer syndrome	VCV001325663	17	41245213	17	43093196	1325663	1315928	rs1348270931	NC_000017.11:43093195:T:A	single nucleotide variant	missense variant|intron variant	Benign	Apr 19, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2315T>C (p.Val772Ala)	BRCA1	V772A, V725A, V476A, V684A, V702A, V724A, V731A, V771A, V604A, V644A, V660A, V661A, V730A, V746A, V745A, V769A, V645A, V683A, V701A, V704A, V705A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041809	17	41245233	17	43093216	41809	50248	rs80357467	NC_000017.11:43093215:A:G	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2286A>T (p.Arg762Ser)	BRCA1	R762S, R715S, R635S, R651S, R714S, R736S, R634S, R650S, R674S, R694S, R720S, R692S, R695S, R721S, R735S, R761S, R466S, R594S, R673S, R691S, R759S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054522	17	41245262	17	43093245	54522	69189	rs273898682	NC_000017.11:43093244:T:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.2207A>C (p.Glu736Ala)	BRCA1	E736A, E689A, E440A, E609A, E668A, E694A, E733A, E735A, E624A, E625A, E647A, E648A, E695A, E710A, E568A, E665A, E688A, E608A, E666A, E669A, E709A	Hereditary breast ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000037455	17	41245341	17	43093324	37455	46011	rs397507196	NC_000017.11:43093323:T:G	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2180C>T (p.Pro727Leu)	BRCA1	P727L, P680L, P599L, P639L, P659L, P660L, P615L, P657L, P686L, P724L, P726L, P431L, P559L, P600L, P700L, P701L, P616L, P638L, P656L, P679L, P685L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054486	17	41245368	17	43093351	54486	69153	rs80356912	NC_000017.11:43093350:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.2167A>G (p.Asn723Asp)	BRCA1	N723D, N676D, N596D, N611D, N696D, N722D, N612D, N656D, N427D, N595D, N635D, N652D, N655D, N682D, N697D, N555D, N634D, N653D, N675D, N681D, N720D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037454	17	41245381	17	43093364	37454	46010	rs4986845	NC_000017.11:43093363:T:C	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2155A>G (p.Lys719Glu)	BRCA1	K672E, K551E, K630E, K649E, K671E, K677E, K678E, K692E, K423E, K652E, K591E, K648E, K693E, K718E, K592E, K607E, K608E, K631E, K651E, K716E	BRCA1-related cancer predisposition	VCV000037452	17	41245393	17	43093376	37452	46008	rs80357147	NC_000017.11:43093375:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.2083G>T (p.Asp695Tyr)	BRCA1	D695Y, D648Y, D527Y, D567Y, D583Y, D584Y, D628Y, D668Y, D653Y, D654Y, D399Y, D607Y, D627Y, D669Y, D568Y, D606Y, D624Y, D625Y, D647Y, D692Y, D694Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054456	17	41245465	17	43093448	54456	69123	rs28897681	NC_000017.11:43093447:C:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.2077G>T (p.Asp693Tyr)	BRCA1	D693Y, D646Y, D605Y, D625Y, D626Y, D666Y, D690Y, D397Y, D565Y, D581Y, D645Y, D692Y, D525Y, D566Y, D582Y, D623Y, D651Y, D652Y, D604Y, D622Y, D667Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125534	17	41245471	17	43093454	125534	131072	rs4986850	NC_000017.11:43093453:C:A	single nucleotide variant	missense variant|intron variant	Benign	Dec 17, 2010	no assertion criteria provided							
NM_007294.4(BRCA1):c.2077G>A (p.Asp693Asn)	BRCA1	D693N, D646N, D582N, D605N, D622N, D652N, D690N, D397N, D565N, D581N, D626N, D651N, D692N, D525N, D566N, D645N, D666N, D604N, D623N, D625N, D667N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041808	17	41245471	17	43093454	41808	50247	rs4986850	NC_000017.11:43093453:C:T	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2002C>T (p.Leu668Phe)	BRCA1	L668F, L621F, L541F, L665F, L500F, L556F, L579F, L580F, L600F, L627F, L641F, L540F, L598F, L601F, L620F, L667F, L372F, L557F, L597F, L626F, L642F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037441	17	41245546	17	43093529	37441	45997	rs80357250	NC_000017.11:43093528:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1974G>A (p.Met658Ile)	BRCA1	M611I, M658I, M546I, M547I, M655I, M362I, M531I, M591I, M490I, M569I, M570I, M587I, M588I, M617I, M632I, M530I, M590I, M610I, M616I, M631I, M657I	Hereditary breast ovarian cancer syndrome	VCV001168433	17	41245574	17	43093557	1168433	1157986	rs55678461	NC_000017.11:43093556:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 14, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1927A>G (p.Ser643Gly)	BRCA1	S643G, S596G, S347G, S516G, S572G, S595G, S617G, S554G, S576G, S602G, S531G, S616G, S642G, S475G, S515G, S532G, S555G, S573G, S575G, S601G, S640G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054402	17	41245621	17	43093604	54402	69069	rs80357105	NC_000017.11:43093603:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.1924G>C (p.Asp642His)	BRCA1	D642H, D595H, D572H, D639H, D641H, D514H, D531H, D594H, D616H, D346H, D515H, D553H, D571H, D574H, D575H, D600H, D474H, D530H, D554H, D601H, D615H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054401	17	41245624	17	43093607	54401	69068	rs80357344	NC_000017.11:43093606:C:G	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1865C>T (p.Ala622Val)	BRCA1	A622V, A575V, A326V, A454V, A495V, A555V, A580V, A581V, A595V, A596V, A511V, A533V, A551V, A552V, A621V, A510V, A554V, A619V, A494V, A534V, A574V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054371	17	41245683	17	43093666	54371	69038	rs56039126	NC_000017.11:43093665:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1834A>G (p.Arg612Gly)	BRCA1	R612G, R565G, R500G, R571G, R611G, R524G, R545G, R564G, R570G, R586G, R316G, R484G, R542G, R585G, R444G, R485G, R501G, R523G, R541G, R544G, R609G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054367	17	41245714	17	43093697	54367	69034	rs80357245	NC_000017.11:43093696:T:C	single nucleotide variant	intron variant|missense variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.1789G>A (p.Glu597Lys)	BRCA1	E597K, E550K, E301K, E527K, E469K, E470K, E508K, E530K, E596K, E429K, E486K, E555K, E570K, E571K, E594K, E485K, E509K, E526K, E529K, E549K, E556K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041806	17	41245759	17	43093742	41806	50245	rs55650082	NC_000017.11:43093741:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1703C>T (p.Pro568Leu)	BRCA1	P568L, P521L, P441L, P541L, P456L, P479L, P497L, P520L, P527L, P542L, P565L, P480L, P498L, P500L, P567L, P272L, P400L, P440L, P457L, P501L, P526L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054329	17	41245845	17	43093828	54329	68996	rs80356910	NC_000017.11:43093827:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.1648A>C (p.Asn550His)	BRCA1	N550H, N503H, N461H, N482H, N254H, N382H, N479H, N483H, N508H, N523H, N439H, N480H, N502H, N524H, N422H, N423H, N438H, N462H, N509H, N547H, N549H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037423	17	41245900	17	43093883	37423	45979	rs56012641	NC_000017.11:43093882:T:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1616C>T (p.Thr539Met)	BRCA1	T539M, T492M, T371M, T412M, T469M, T512M, T513M, T538M, T411M, T471M, T472M, T498M, T427M, T450M, T468M, T497M, T243M, T428M, T451M, T491M, T536M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054310	17	41245932	17	43093915	54310	68977	rs80357374	NC_000017.11:43093914:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.1534C>T (p.Leu512Phe)	BRCA1	L512F, L465F, L216F, L400F, L441F, L442F, L471F, L509F, L384F, L424F, L445F, L486F, L344F, L401F, L444F, L470F, L385F, L423F, L464F, L485F, L511F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037420	17	41246014	17	43093997	37420	45976	rs41286294	NC_000017.11:43093996:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.1511G>A (p.Arg504His)	BRCA1	R504H, R457H, R415H, R433H, R434H, R456H, R463H, R208H, R336H, R377H, R392H, R462H, R376H, R436H, R477H, R501H, R393H, R416H, R437H, R478H, R503H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054278	17	41246037	17	43094020	54278	68945	rs56272539	NC_000017.11:43094019:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1487G>A (p.Arg496His)	BRCA1	R496H, R449H, R385H, R408H, R425H, R428H, R495H, R328H, R368H, R426H, R448H, R469H, R200H, R369H, R455H, R470H, R384H, R407H, R429H, R454H, R493H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041805	17	41246061	17	43094044	41805	50244	rs28897677	NC_000017.11:43094043:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1486C>T (p.Arg496Cys)	BRCA1	R496C, R449C, R200C, R454C, R384C, R407C, R455C, R493C, R495C, R328C, R408C, R426C, R428C, R448C, R469C, R368C, R369C, R385C, R425C, R429C, R470C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037416	17	41246062	17	43094045	37416	45972	rs28897676	NC_000017.11:43094044:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1474A>G (p.Ile492Val)	BRCA1	I445V, I492V, I364V, I365V, I381V, I403V, I444V, I489V, I196V, I422V, I425V, I451V, I404V, I421V, I491V, I324V, I380V, I424V, I450V, I465V, I466V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000660456	17	41246074	17	43094057	660456	646028	rs1597875858	NC_000017.11:43094056:T:C	single nucleotide variant	intron variant|missense variant	Benign/Likely benign	Jul 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1458T>A (p.Phe486Leu)	BRCA1	F486L, F439L, F416L, F419L, F460L, F318L, F359L, F398L, F418L, F459L, F485L, F358L, F374L, F397L, F483L, F190L, F375L, F415L, F438L, F444L, F445L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054259	17	41246090	17	43094073	54259	68926	rs80357400	NC_000017.11:43094072:A:T	single nucleotide variant	intron variant|missense variant	Benign/Likely benign	Sep 9, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1456T>C (p.Phe486Leu)	BRCA1	F486L, F439L, F374L, F375L, F416L, F419L, F444L, F358L, F398L, F438L, F483L, F318L, F397L, F415L, F485L, F190L, F359L, F418L, F445L, F459L, F460L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054258	17	41246092	17	43094075	54258	68925	rs55906931	NC_000017.11:43094074:A:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1427A>G (p.His476Arg)	BRCA1	H476R, H429R, H364R, H434R, H449R, H180R, H308R, H365R, H388R, H405R, H406R, H428R, H450R, H475R, H349R, H409R, H473R, H348R, H387R, H408R, H435R	not provided|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054251	17	41246121	17	43094104	54251	68918	rs55720177	NC_000017.11:43094103:T:C	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1418A>T (p.Asn473Ile)	BRCA1	N473I, N426I, N345I, N346I, N361I, N385I, N432I, N470I, N177I, N384I, N402I, N405I, N447I, N472I, N362I, N406I, N431I, N305I, N403I, N425I, N446I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054249	17	41246130	17	43094113	54249	68916	rs80357057	NC_000017.11:43094112:T:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.1418A>G (p.Asn473Ser)	BRCA1	N473S, N426S, N177S, N384S, N405S, N406S, N345S, N361S, N402S, N431S, N432S, N446S, N472S, N362S, N403S, N425S, N305S, N346S, N385S, N447S, N470S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054248	17	41246130	17	43094113	54248	68915	rs80357057	NC_000017.11:43094112:T:C	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1383T>A (p.Phe461Leu)	BRCA1	F461L, F414L, F419L, F458L, F460L, F334L, F372L, F373L, F394L, F413L, F435L, F293L, F333L, F349L, F390L, F391L, F393L, F434L, F165L, F350L, F420L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054228	17	41246165	17	43094148	54228	68895	rs56046357	NC_000017.11:43094147:A:T	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.1233T>G (p.Asp411Glu)	BRCA1	D411E, D364E, D300E, D323E, D344E, D410E, D283E, D322E, D340E, D384E, D385E, D408E, D115E, D243E, D284E, D299E, D370E, D341E, D343E, D363E, D369E	BRCA1-related cancer predisposition	VCV000041804	17	41246315	17	43094298	41804	50243	rs80357024	NC_000017.11:43094297:A:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.1159T>A (p.Ser387Thr)	BRCA1	S387T, S340T, S219T, S276T, S298T, S345T, S91T, S260T, S320T, S384T, S386T, S259T, S275T, S299T, S316T, S317T, S319T, S361T, S339T, S346T, S360T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000231852	17	41246389	17	43094372	231852	236139	rs876659403	NC_000017.11:43094371:A:T	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.1137T>G (p.Ile379Met)	BRCA1	I379M, I332M, I291M, I309M, I337M, I352M, I353M, I267M, I268M, I290M, I338M, I378M, I83M, I211M, I251M, I252M, I308M, I311M, I312M, I331M, I376M	Hereditary breast ovarian cancer syndrome|BRCA1-related cancer predisposition|Familial cancer of breast|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|not provided|Familial cancer of breast	VCV000054143	17	41246411	17	43094394	54143	68810	rs56128296	NC_000017.11:43094393:A:C	single nucleotide variant	intron variant|missense variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1105G>A (p.Asp369Asn)	BRCA1	D369N, D322N, D257N, D73N, D201N, D281N, D302N, D321N, D327N, D328N, D241N, D258N, D280N, D299N, D301N, D342N, D343N, D366N, D368N, D242N, D298N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037390	17	41246443	17	43094426	37390	45946	rs56056711	NC_000017.11:43094425:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1067A>G (p.Gln356Arg)	BRCA1	Q356R, Q309R, Q314R, Q315R, Q353R, Q244R, Q268R, Q288R, Q329R, Q355R, Q60R, Q228R, Q245R, Q267R, Q289R, Q188R, Q229R, Q285R, Q286R, Q308R, Q330R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041803	17	41246481	17	43094464	41803	50242	rs1799950	NC_000017.11:43094463:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1036C>T (p.Pro346Ser)	BRCA1	P346S, P299S, P275S, P298S, P304S, P320S, P345S, P178S, P218S, P234S, P50S, P235S, P257S, P276S, P279S, P305S, P319S, P343S, P219S, P258S, P278S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037389	17	41246512	17	43094495	37389	45945	rs80357015	NC_000017.11:43094494:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.1001C>T (p.Pro334Leu)	BRCA1	P334L, P287L, P286L, P292L, P333L, P166L, P206L, P223L, P245L, P246L, P263L, P307L, P308L, P207L, P266L, P267L, P331L, P222L, P264L, P293L, P38L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054099	17	41246547	17	43094530	54099	68766	rs41286290	NC_000017.11:43094529:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.997A>G (p.Thr333Ala)	BRCA1	T333A, T286A, T206A, T222A, T244A, T245A, T266A, T292A, T221A, T262A, T263A, T306A, T330A, T332A, T37A, T165A, T265A, T291A, T205A, T285A, T307A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000184709	17	41246551	17	43094534	184709	185085	rs786201634	NC_000017.11:43094533:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.946A>G (p.Ser316Gly)	BRCA1	S316G, S269G, S148G, S20G, S245G, S289G, S227G, S274G, S315G, S204G, S268G, S275G, S290G, S313G, S188G, S189G, S205G, S228G, S246G, S248G, S249G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037709	17	41246602	17	43094585	37709	46265	rs55874646	NC_000017.11:43094584:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.891G>T (p.Met297Ile)	BRCA1	M297I, M250I, M169I, M208I, M227I, M230I, M249I, M186I, M1I, M209I, M226I, M256I, M270I, M294I, M129I, M255I, M271I, M170I, M185I, M229I, M296I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000812549	17	41246657	17	43094640	812549	800792	rs80357103	NC_000017.11:43094639:C:A	single nucleotide variant	missense variant|initiator_codon_variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.891G>A (p.Met297Ile)	BRCA1	M297I, M250I, M129I, M208I, M227I, M229I, M230I, M271I, M1I, M255I, M270I, M169I, M294I, M296I, M170I, M185I, M186I, M209I, M226I, M249I, M256I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055743	17	41246657	17	43094640	55743	70410	rs80357103	NC_000017.11:43094639:C:T	single nucleotide variant	missense variant|initiator_codon_variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.839C>G (p.Ala280Gly)	BRCA1	A280G, A233G, A152G, A153G, A212G, A253G, A168G, A192G, A209G, A213G, A112G, A232G, A279G, A169G, A191G, A210G, A238G, A239G, A254G, A277G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055731	17	41246709	17	43094692	55731	70398	rs80357199	NC_000017.11:43094691:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.827C>G (p.Thr276Arg)	BRCA1	T276R, T229R, T149R, T209R, T250R, T164R, T205R, T208R, T234R, T148R, T165R, T188R, T235R, T275R, T108R, T187R, T206R, T228R, T249R, T273R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037706	17	41246721	17	43094704	37706	46262	rs80357436	NC_000017.11:43094703:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.824G>A (p.Gly275Asp)	BRCA1	G275D, G228D, G248D, G274D, G164D, G227D, G272D, G147D, G187D, G204D, G207D, G234D, G249D, G107D, G148D, G163D, G208D, G233D, G186D, G205D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055726	17	41246724	17	43094707	55726	70393	rs397509327	NC_000017.11:43094706:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.823G>A (p.Gly275Ser)	BRCA1	G275S, G228S, G205S, G272S, G107S, G148S, G164S, G186S, G207S, G208S, G234S, G249S, G187S, G204S, G233S, G274S, G147S, G163S, G227S, G248S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055725	17	41246725	17	43094708	55725	70392	rs8176153	NC_000017.11:43094707:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.811G>A (p.Val271Met)	BRCA1	V271M, V224M, V103M, V159M, V183M, V200M, V201M, V230M, V270M, V143M, V160M, V182M, V203M, V244M, V144M, V204M, V223M, V229M, V245M, V268M	BRCA1-related cancer predisposition|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified	VCV000055720	17	41246737	17	43094720	55720	70387	rs80357244	NC_000017.11:43094719:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.736T>G (p.Leu246Val)	BRCA1	L246V, L199V, L118V, L119V, L134V, L219V, L243V, L176V, L179V, L201V, L204V, L245V, L158V, L175V, L198V, L220V, L135V, L157V, L178V, L205V, L78V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041835	17	41246812	17	43094795	41835	50274	rs28897675	NC_000017.11:43094794:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.716A>G (p.His239Arg)	BRCA1	H239R, H192R, H128R, H150R, H194R, H213R, H112R, H191R, H238R, H71R, H168R, H169R, H171R, H172R, H197R, H111R, H127R, H151R, H198R, H212R, H236R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055677	17	41246832	17	43094815	55677	70344	rs80357396	NC_000017.11:43094814:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.652T>G (p.Leu218Val)	BRCA1	L171V, L218V, L147V, L191V, L91V, L148V, L170V, L173V, L192V, L90V, L215V, L217V	not specified	VCV001684697	17	41247881	17	43095864	1684697	1676725	rs765950064	NC_000017.11:43095863:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	May 4, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.641A>G (p.Asp214Gly)	BRCA1	D214G, D167G, D143G, D166G, D87G, D144G, D211G, D187G, D169G, D188G, D213G, D86G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037689	17	41247892	17	43095875	37689	46245	rs55680408	NC_000017.11:43095874:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 29, 2017	reviewed by expert panel							
NM_007294.3(BRCA1):c.[594-2A>C;641A>G]	BRCA1	D214G, D167G, D143G, D166G, D87G, D144G, D211G, D187G, D169G, D188G, D213G, D86G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000236265	17|17	41247941	17|17	43095924	236265	46242|46245	rs80358033|rs55680408	NC_000017.11:43095923:T:G|NC_000017.11:43095874:T:C	Haplotype	splice acceptor variant|intron variant|missense variant|non-coding transcript variant	Benign	Apr 15, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.571G>A (p.Val191Ile)	BRCA1	V191I, V144I, V120I, V121I, V146I, V64I, V164I, V165I, V188I, V190I, V143I, V63I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037684	17	41249283	17	43097266	37684	46240	rs80357090	NC_000017.11:43097265:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.557C>A (p.Ser186Tyr)	BRCA1	S186Y, S139Y, S183Y, S115Y, S185Y, S59Y, S116Y, S160Y, S138Y, S141Y, S159Y, S58Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055635	17	41249297	17	43097280	55635	70302	rs55688530	NC_000017.11:43097279:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.536A>G (p.Tyr179Cys)	BRCA1	Y179C, Y132C, Y109C, Y178C, Y51C, Y134C, Y176C, Y131C, Y152C, Y153C, Y52C, Y108C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037661	17	41251803	17	43099786	37661	46217	rs56187033	NC_000017.11:43099785:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.508C>T (p.Arg170Trp)	BRCA1	R170W, R123W, R144W, R99W, R100W, R122W, R167W, R169W, R43W, R125W, R143W, R42W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055393	17	41251831	17	43099814	55393	70060	rs80357325	NC_000017.11:43099813:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.463C>G (p.Gln155Glu)	BRCA1	Q155E, Q108E, Q107E, Q128E, Q27E, Q84E, Q85E, Q110E, Q129E, Q152E, Q154E, Q28E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055247	17	41251876	17	43099859	55247	69914	rs80357180	NC_000017.11:43099858:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.427G>A (p.Glu143Lys)	BRCA1	E143K, E96K, E117K, E73K, E140K, E16K, E99K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037580	17	41256153	17	43104136	37580	46136	rs80356991	NC_000017.11:43104135:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.425C>A (p.Pro142His)	BRCA1	P142H, P95H, P116H, P139H, P15H, P72H, P98H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041823	17	41256155	17	43104138	41823	50262	rs55971303	NC_000017.11:43104137:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.397C>T (p.Arg133Cys)	BRCA1	R133C, R86C, R107C, R63C, R6C, R130C, R89C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055067	17	41256183	17	43104166	55067	69734	rs80357457	NC_000017.11:43104165:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.396C>A (p.Asn132Lys)	BRCA1	N132K, N85K, N129K, N5K, N62K, N88K, N106K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055064	17	41256184	17	43104167	55064	69731	rs80357413	NC_000017.11:43104166:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.370A>G (p.Ile124Val)	BRCA1	I124V, I77V, I121V, I80V, I54V, I98V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054971	17	41256210	17	43104193	54971	69638	rs80357448	NC_000017.11:43104192:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.314A>G (p.Tyr105Cys)	BRCA1	Y105C, Y58C, Y35C, Y102C, Y61C, Y79C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054780	17	41256266	17	43104249	54780	69447	rs28897673	NC_000017.11:43104248:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.305C>G (p.Ala102Gly)	BRCA1	A102G, A55G, A76G, A99G, A58G, A32G	BRCA1-related cancer predisposition	VCV000037505	17	41256275	17	43104258	37505	46061	rs80357190	NC_000017.11:43104257:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.302_303delinsGA (p.Tyr101Ter)	BRCA1	Y101*, Y54*, D98G, Y57*, Y31*, Y75*	Hereditary breast ovarian cancer syndrome	VCV001679002	17	41256277 - 41256278	17	43104260 - 43104261	1679002	1670796	rs2154550229	NC_000017.11:43104259:AT:TC	Indel	nonsense|non-coding transcript variant|missense variant	Pathogenic	Apr 19, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.303T>A (p.Tyr101Ter)	BRCA1	Y101*, Y54*, D98E, Y31*, Y57*, Y75*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266331	17	41256277	17	43104260	266331	262010	rs80356936	NC_000017.11:43104259:A:T	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.303T>G (p.Tyr101Ter)	BRCA1	Y101*, Y54*, D98E, Y57*, Y75*, Y31*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054758	17	41256277	17	43104260	54758	69425	rs80356936	NC_000017.11:43104259:A:C	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.287A>T (p.Asp96Val)	BRCA1	D49V, D96V, D26V, D70V, D52V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000868827	17	41256899	17	43104882	868827	854438	rs864622444	NC_000017.11:43104881:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jun 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.287A>G (p.Asp96Gly)	BRCA1	D96G, D49G, D52G, D26G, D70G	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome	VCV000220258	17	41256899	17	43104882	220258	222681	rs864622444	NC_000017.11:43104881:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Aug 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.212G>C (p.Arg71Thr)	BRCA1	R71T, R24T	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000267512	17	41258473	17	43106456	267512	262989	rs80356913	NC_000017.11:43106455:C:G	single nucleotide variant	missense variant	Pathogenic	May 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.212G>T (p.Arg71Met)	BRCA1	R71M, R24M	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000185705	17	41258473	17	43106456	185705	185125	rs80356913	NC_000017.11:43106455:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.212G>A (p.Arg71Lys)	BRCA1	R71K, R24K	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Fanconi anemia, complementation group S	VCV000054471	17	41258473	17	43106456	54471	69138	rs80356913	NC_000017.11:43106455:C:T	single nucleotide variant	missense variant	Pathogenic	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.211A>G (p.Arg71Gly)	BRCA1	R71G, R24G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017693	17	41258474	17	43106457	17693	32732	rs80357382	NC_000017.11:43106456:T:C	single nucleotide variant	missense variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.199G>T (p.Asp67Tyr)	BRCA1	D67Y, D20Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054431	17	41258486	17	43106469	54431	69098	rs80357102	NC_000017.11:43106468:C:A	single nucleotide variant	missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.192T>G (p.Cys64Trp)	BRCA1	C64W, C17W	Breast neoplasm|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000224427	17	41258493	17	43106476	224427	226211	rs587781632	NC_000017.11:43106475:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 18, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.191G>C (p.Cys64Ser)	BRCA1	C64S, C17S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000462571	17	41258494	17	43106477	462571	468251	rs55851803	NC_000017.11:43106476:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.191G>A (p.Cys64Tyr)	BRCA1	C64Y, C17Y	BRCA1-related cancer predisposition	VCV000054400	17	41258494	17	43106477	54400	69067	rs55851803	NC_000017.11:43106476:C:T	single nucleotide variant	missense variant	Pathogenic	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.190T>C (p.Cys64Arg)	BRCA1	C64R, C17R, M1T	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054394	17	41258495	17	43106478	54394	69061	rs80357064	NC_000017.11:43106477:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Nov 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.190T>G (p.Cys64Gly)	BRCA1	C64G, C17G, M1R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000017660	17	41258495	17	43106478	17660	32699	rs80357064	NC_000017.11:43106477:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Dec 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.182G>A (p.Cys61Tyr)	BRCA1	C61Y, C14Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000054364	17	41258503	17	43106486	54364	69031	rs80357093	NC_000017.11:43106485:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.181T>C (p.Cys61Arg)	BRCA1	C61R, C14R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000054360	17	41258504	17	43106487	54360	69027	rs28897672	NC_000017.11:43106486:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.181T>A (p.Cys61Ser)	BRCA1	C61S, C14S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054359	17	41258504	17	43106487	54359	69026	rs28897672	NC_000017.11:43106486:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Apr 2, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.181T>G (p.Cys61Gly)	BRCA1	C61G, C14G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017661	17	41258504	17	43106487	17661	32700	rs28897672	NC_000017.11:43106486:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.140G>T (p.Cys47Phe)	BRCA1	C47F	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	VCV000054247	17	41258545	17	43106528	54247	68914	rs80357150	NC_000017.11:43106527:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.140G>A (p.Cys47Tyr)	BRCA1	C47Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054246	17	41258545	17	43106528	54246	68913	rs80357150	NC_000017.11:43106527:C:T	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.139T>C (p.Cys47Arg)	BRCA1	C47R	Hereditary breast ovarian cancer syndrome	VCV000651975	17	41258546	17	43106529	651975	646060	rs80357370	NC_000017.11:43106528:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jan 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.139T>A (p.Cys47Ser)	BRCA1	C47S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267508	17	41258546	17	43106529	267508	262990	rs80357370	NC_000017.11:43106528:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.133A>C (p.Lys45Gln)	BRCA1	K45Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000183950	17	41267744	17	43115727	183950	185127	rs769650474	NC_000017.11:43115726:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.131G>C (p.Cys44Ser)	BRCA1	C44S	Hereditary breast ovarian cancer syndrome	VCV000868170	17	41267746	17	43115729	868170	854771	rs80357446	NC_000017.11:43115728:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jul 25, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.131G>T (p.Cys44Phe)	BRCA1	C44F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054200	17	41267746	17	43115729	54200	68867	rs80357446	NC_000017.11:43115728:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.131G>A (p.Cys44Tyr)	BRCA1	C44Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054199	17	41267746	17	43115729	54199	68866	rs80357446	NC_000017.11:43115728:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.130T>C (p.Cys44Arg)	BRCA1	C44R	Hereditary breast ovarian cancer syndrome	VCV000054192	17	41267747	17	43115730	54192	68859	rs80357327	NC_000017.11:43115729:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Mar 6, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.130T>A (p.Cys44Ser)	BRCA1	C44S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054191	17	41267747	17	43115730	54191	68858	rs80357327	NC_000017.11:43115729:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.122A>T (p.His41Leu)	BRCA1	H41L	not provided|Hereditary breast ovarian cancer syndrome|Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000230862	17	41267755	17	43115738	230862	236179	rs80357276	NC_000017.11:43115737:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Sep 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.122A>G (p.His41Arg)	BRCA1	H41R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054166	17	41267755	17	43115738	54166	68833	rs80357276	NC_000017.11:43115737:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.121C>T (p.His41Tyr)	BRCA1	H41Y	not provided|BRCA1-related cancer predisposition|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000580736	17	41267756	17	43115739	580736	569193	rs1060502353	NC_000017.11:43115738:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Aug 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.117T>G (p.Cys39Trp)	BRCA1	C39W	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000267497	17	41267760	17	43115743	267497	262993	rs886040898	NC_000017.11:43115742:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jan 30, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.116G>T (p.Cys39Phe)	BRCA1	C39F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037393	17	41267761	17	43115744	37393	45949	rs80357498	NC_000017.11:43115743:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Aug 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.116G>A (p.Cys39Tyr)	BRCA1	C39Y	not provided|Hereditary cancer-predisposing syndrome|Breast neoplasm|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000037392	17	41267761	17	43115744	37392	45948	rs80357498	NC_000017.11:43115743:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Dec 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.115T>G (p.Cys39Gly)	BRCA1	C39G	Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000054153	17	41267762	17	43115745	54153	68820	rs80357164	NC_000017.11:43115744:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.115T>C (p.Cys39Arg)	BRCA1	C39R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054152	17	41267762	17	43115745	54152	68819	rs80357164	NC_000017.11:43115744:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.115T>A (p.Cys39Ser)	BRCA1	C39S	Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000054151	17	41267762	17	43115745	54151	68818	rs80357164	NC_000017.11:43115744:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.110C>G (p.Thr37Arg)	BRCA1	T37R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054132	17	41267767	17	43115750	54132	68799	rs80356880	NC_000017.11:43115749:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.110C>A (p.Thr37Lys)	BRCA1	T37K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054131	17	41267767	17	43115750	54131	68798	rs80356880	NC_000017.11:43115749:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.77T>A (p.Ile26Asn)	BRCA1	I26N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252890	17	41276037	17	43124020	252890	247291	rs879255496	NC_000017.11:43124019:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jul 15, 2010	no assertion criteria provided							
NM_007294.4(BRCA1):c.72T>G (p.Cys24Trp)	BRCA1	C24W	Hereditary breast ovarian cancer syndrome	VCV000652430	17	41276042	17	43124025	652430	646062	rs1597923232	NC_000017.11:43124024:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Aug 9, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.71G>A (p.Cys24Tyr)	BRCA1	C24Y	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055678	17	41276043	17	43124026	55678	70345	rs80357198	NC_000017.11:43124025:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.70T>G (p.Cys24Gly)	BRCA1	C24G	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000649351	17	41276044	17	43124027	649351	646063	rs80357410	NC_000017.11:43124026:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	May 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.70T>A (p.Cys24Ser)	BRCA1	C24S	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000638952	17	41276044	17	43124027	638952	646064	rs80357410	NC_000017.11:43124026:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	May 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.70T>C (p.Cys24Arg)	BRCA1	C24R	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055674	17	41276044	17	43124027	55674	70341	rs80357410	NC_000017.11:43124026:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jul 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.65T>C (p.Leu22Ser)	BRCA1	L22S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055656	17	41276049	17	43124032	55656	70323	rs80357438	NC_000017.11:43124031:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.53T>A (p.Met18Lys)	BRCA1	M18K	Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer	VCV000055559	17	41276061	17	43124044	55559	70226	rs80356929	NC_000017.11:43124043:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.53T>C (p.Met18Thr)	BRCA1	M18T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037664	17	41276061	17	43124044	37664	46220	rs80356929	NC_000017.11:43124043:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.3G>A (p.Met1Ile)	BRCA1	M1I	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000431194	17	41276111	17	43124094	431194	424868	rs80357475	NC_000017.11:43124093:C:T	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	May 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3G>C (p.Met1Ile)	BRCA1	M1I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267523	17	41276111	17	43124094	267523	262996	rs80357475	NC_000017.11:43124093:C:G	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3G>T (p.Met1Ile)	BRCA1	M1I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055072	17	41276111	17	43124094	55072	69739	rs80357475	NC_000017.11:43124093:C:A	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.2T>A (p.Met1Lys)	BRCA1	M1K	not provided	VCV000801069	17	41276112	17	43124095	801069	789636	rs80357111	NC_000017.11:43124094:A:T	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Feb 27, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2T>G (p.Met1Arg)	BRCA1	M1R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054746	17	41276112	17	43124095	54746	69413	rs80357111	NC_000017.11:43124094:A:C	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Apr 29, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2T>C (p.Met1Thr)	BRCA1	M1T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054745	17	41276112	17	43124095	54745	69412	rs80357111	NC_000017.11:43124094:A:G	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	May 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1A>G (p.Met1Val)	BRCA1	M1V	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Breast neoplasm|Inherited breast cancer and ovarian cancer|not provided|Hereditary cancer-predisposing syndrome	VCV000054432	17	41276113	17	43124096	54432	69099	rs80357287	NC_000017.11:43124095:T:C	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 9, 2025	criteria provided, multiple submitters, no conflicts							
